arginine vasopressin has been researched along with Disease Models, Animal in 239 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (9.21) | 18.7374 |
| 1990's | 25 (10.46) | 18.2507 |
| 2000's | 70 (29.29) | 29.6817 |
| 2010's | 98 (41.00) | 24.3611 |
| 2020's | 24 (10.04) | 2.80 |
| Authors | Studies |
|---|---|
| Cherepanov, SM; Daikoku, T; Higashida, H; Horike, S; Ichinose, W; Mano, N; Okamoto, H; Shabalova, AA; Shuto, S; Terakawa, J; Watanabe, A; Watanabe, M; Yamaguchi, H; Yamamoto, Y; Yokoyama, S; Yuhi, T | 1 |
| Alenina, N; Alves, DT; Bader, M; Campagnole-Santos, MJ; Coimbra-Campos, LMC; Ferreira, AJ; Martins, AS; Mendes, LF; Popova, E; Qadri, F; Sampaio, WO; Santos, RAS; Todiras, M; Vieira, MAR | 1 |
| Ávila-Blanco, ME; González-Blas, D; Macías-Segura, N; Muñoz-Ortega, M; Ponce-Damian, LD; Quintanar-Stephano, A; Sánchez-Alemán, E; Ventura-Juárez, J | 1 |
| Baba, K; Kataoka, M; Maruyama, T; Miyamoto, T; Nishimura, H; Nishimura, K; Onaka, T; Otsuji, Y; Sanada, K; Sonoda, S; Tanaka, K; Ueno, H; Ueta, Y; Yoshimura, M | 1 |
| Bastiaanssen, TFS; Campos, D; Chetal, S; Chruścicka-Smaga, B; Cryan, JF; Dinan, TG; Druelle, C; Fitzgerald, P; Golubeva, A; Jayaprakash, P; Jeffery, IB; Moloney, GM; Mulder, I; Olavarría-Ramírez, L; Paula Ventura Da Silva, A; Rea, K; Sandhu, K; Savignac, H; Schellekens, H; Sen, P; Sherwin, E | 1 |
| Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P | 1 |
| Chen, Y; Huang, J; Liu, Y; Peng, J; Ren, Y; Tang, L; Wen, M; Yan, X; Yang, L; Zhang, Y; Zheng, X; Zhou, B | 1 |
| Bai, Y; Guo, J; Qi, J; Wang, C; Wang, Z; Wu, M; Yang, W; Zhang, J; Zhang, X; Zhao, F; Zhou, F | 1 |
| Best, C; Brydges, NM; Drake, AJ; Hall, J; Lewis, C; Rule, L; Thomas, KL; Watkin, H | 1 |
| Geng, Z; Tong, Y; Xiong, XQ; Ye, C; Zhang, F; Zhou, YB | 1 |
| Gómez-González, B; Quintanar-Stephano, A; Viñuela-Berni, V | 1 |
| Chen, W; Lei, C; Ouyang, S; Zeng, G | 1 |
| Bennet, L; Davidson, JO; Drury, PP; Gunn, AJ; Kasai, M; Lear, CA; Miyagi, E | 1 |
| Dombret, C; Hardin-Pouzet, H; Mhaouty-Kodja, S; Naulé, L; Parmentier, C; Trouillet, AC | 1 |
| Bachelor, ME; Balapattabi, K; Cunningham, JT; Cunningham, RL; Little, JT | 1 |
| Ge, N; Huang, Y; Li, S; Li, T; Liu, C; Liu, K; Wang, Y; Zhu, X | 1 |
| Aleksandrowicz, M; Kozniewska, E | 1 |
| Agustín-Pavón, C; Bose, A; Kul, E; Lanuza, E; Martín-Sánchez, A; Martínez-García, F; Martínez-Martínez, FJ; Martínez-Rodríguez, E; Santos, M; Stork, O | 1 |
| Baba, K; Fujitani, T; Kawasaki, M; Maruyama, T; Matsuura, T; Motojima, Y; Nishimura, H; Nishimura, K; Ohnishi, H; Onaka, T; Sakai, A; Sanada, K; Sonoda, S; Suzuki, H; Tanaka, K; Tsukamoto, M; Ueta, Y; Yamanaka, Y; Yoshimura, M | 1 |
| Fei, SJ; Miao, B; Su, Z; Xu, MQ; Yang, MJ; Zhang, JF | 1 |
| Colwell, CS; Han, HC; Hong, EH; Jin, X; Jung, WW; Kang, HK; Kim, MN; Kim, WB; Kim, YB; Kim, YI; Kim, YS; Shim, WJ | 1 |
| Huang, P; Huang, X; Li, H; Wang, P; Xie, G | 1 |
| Bai, SZ; Dai, YC; Han, JS; Han, SP; Hu, Y; Lan, XY; Wu, J; Zhang, HF; Zhang, R | 1 |
| Alvear-Perez, R; Bonnet, D; De Mota, N; Estéoulle, L; Flahault, A; Girault-Sotias, PE; Iturrioz, X; Keck, M; Llorens-Cortes, C; Ramanoudjame, SM | 1 |
| Albuisson, E; Grandmougin, D; Klein, T; Levy, B; Liu, Y; Orlowski, S; Tran, N | 1 |
| Cohen, H; Danan, D; Todder, D; Zohar, J | 1 |
| Akgul, E; Diril, S; Haciyakupoglu, E; Haciyakupoglu, S; Nazlican, E; Polat, S; Sencar, L; Yilmaz, DM | 1 |
| Coldren, KM; Hasser, EM; Heesch, CM; Kline, DD; Li, DP | 1 |
| Han, JS; Han, SP; Xu, XJ; Zhang, HF; Zhang, R | 1 |
| Du, AL; Jiang, HB; Luo, HY; Luo, XQ; Ma, RQ; Shi, CH; Xu, YM; Yang, J | 1 |
| Jiang, LG; Shao, Y; Zhang, HW; Zhang, Z | 1 |
| Li, CY; Li, DY; Li, J; Liu, X; Qi, CL; Qu, X; Zhang, L | 1 |
| Chen, HD; Chen, XX; He, JJ; Jiang, LY; Sun, XJ; Wang, XZ; Zhong, S | 1 |
| Bailey, M; Bailey, SR; Bellomo, R; Booth, LC; Burrell, LM; Calzavacca, P; Lankadeva, YR; May, CN | 1 |
| Ando, F; Kagechika, H; Kondo, Y; Mori, S; Morimoto, T; Nomura, N; Rai, T; Sasaki, S; Sohara, E; Uchida, S; Yui, N | 1 |
| Bao, Y; Feng, Z; Ma, L; Ou, Y; Qi, S; Qiu, B; Wu, G; Zhou, M | 1 |
| Arima, H; Azuma, Y; Banno, R; Goto, M; Hagiwara, D; Ito, Y; Iwama, S; Miyata, T; Morishita, Y; Onoue, T; Suga, H; Takagi, H; Tochiya, M; Tsunekawa, T | 1 |
| Feng, ZP; Gong, HD; Li, K; Liu, YW; Ou, YC; Peng, JJ; Qi, ST; Qiu, BH; Wang, YJ; Zhou, MF | 1 |
| Hew-Butler, T; Pollard-McGrandy, A; Smith-Hale, V; VanSumeren, M | 1 |
| Ciosek, J; Drobnik, J | 1 |
| Liebl, C; Müller, MB; Scharf, SH; Schmidt, MV; Sterlemann, V | 1 |
| Juif, PE; Poisbeau, P | 1 |
| Ferenczi, S; Kovács, KJ; Milanés, MV; Núnez, C; Pintér-Kübler, B; Polyák, A; Zelei, E | 1 |
| Chuang, CL; Huang, HC; Huo, TI; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Allieri, F; Collado, P; Gotti, S; Guillamón, A; Melcangi, RC; Panzica, GC; Spigolon, G | 1 |
| Brønd, L; Christensen, S; Graebe, M; Hadrup, N; Jonassen, TE; Müllertz, KM; Nielsen, J; Nielsen, S; Torp, M | 1 |
| Basso, PJ; Oliveira-Pelegrin, GR; Rocha, MJ | 1 |
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Arima, H; Asai, N; Azuma, Y; Banno, R; Goto, M; Hagiwara, D; Ito, Y; Morishita, Y; Oiso, Y; Shiota, A; Suga, H; Sugimura, Y; Takahashi, M; Wenjun, L | 1 |
| Lukas, M; Neumann, ID | 1 |
| Cano-Peñalver, JL; de Frutos, S; Dedhar, S; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Serrano, I | 1 |
| Elliott, J; Kenward, H; Pelligand, L | 1 |
| Jiang, RY; Lai, WY; Lin, S; Ren, H; Shen, QB; Wu, ZL; Xu, DL; Ye, TC; Zeng, QC | 1 |
| Adamo, S; Costa, A; Murfuni, I; Pelosi, L; Scicchitano, BM; Sica, G; Toschi, A | 1 |
| Gibson-Corley, KN; Grobe, JL; Hunter, SK; Leslie, KK; Min, JY; Pearson, NA; Sandgren, JA; Santillan, DA; Santillan, MK; Scroggins, SM; Zamba, GK | 1 |
| Carlini, VP; Fiol de Cuneo, M; Kumar, P; Poretti, MB; Rask-Andersen, M; Rubiales de Barioglio, S; Schiöth, HB | 1 |
| Aguila, FA; Batalhão, ME; Cárnio, EC; Rocha, MJ; Tazinafo, LF; Wahab, F | 1 |
| Bugaj, V; Chen, Y; Kohan, DE; Mironova, E; Pao, AC; Roos, KP; Stockand, JD | 1 |
| Han, JS; Han, SP; Jing, WL; Li, J; Qian, Y; Shou, XJ; Xu, XJ; Zhang, HF; Zhang, R; Zhou, Y | 1 |
| Harris, PC; Hopp, K; Irazabal, MV; Torres, VE; Wang, X; Ye, H | 1 |
| Cai, L; Li, R; Zhou, JN | 1 |
| Gilbert, ML; McKnight, GS; Su, T; Yang, L | 1 |
| Atsak, P; Barsegyan, A; Hornberger, WB; Jacobson, PB; Roozendaal, B; van Gaalen, MM | 1 |
| Chen, X; Gao, X; Li, Q; Lu, G; Tang, K | 1 |
| Antunes, VR; Ferreira-Neto, HC; Panizza, Hdo N; Ribeiro, N; Santos, KM | 1 |
| Chen, Z; Meng, Z; Tian, Z; Wu, G; Zhu, J; Zhu, L | 1 |
| Jiang, ZL; Li, JC; Liu, HX; Tang, GR; Xu, LH; Yang, JJ | 1 |
| Carlini, VP; de Cuneo, MF; Perez, MF; Poretti, MB; Rask-Andersen, M; Sawant, RS; Schiöth, HB | 1 |
| Demeter, K; Eszik, I; Ferenczi, S; Fodor, A; Kovács, KJ; Szegedi, V; Török, B; Varga, J; Zelena, D | 1 |
| Colwell, CS; Gad, L; Ghiani, CA; Hitchcock, ON; Kuljis, DA; Loh, DH; MacDowell Kaswan, Z | 1 |
| Bi, W; Friedrich, V; Sehba, FA | 1 |
| Burns, KD; Eckert, D; Ghossein, J; Gutsol, A; Hassouneh, R; Hébert, RL; Nasrallah, R; Zimpelmann, J | 1 |
| Dehpour, AR; Doustimotlagh, AH; Javadi-Paydar, M; Javadian, N; Rahimi, N | 1 |
| Allen, CD; Bae, S; Grigoleit, JS; Hong, J; Lee, S; Vaughan, J | 1 |
| Eiden, LE; Fuxe, K; Gómora, MJ; Hernández, OR; Hernández, VS; Perez de la Mora, M; Zhang, L | 1 |
| Pavlov, TS; Staruschenko, A | 1 |
| Baram, TZ; Lenjavi, MR; Rice, CJ; Sandman, CA | 1 |
| Bourque, CW; Ciura, S; Sharif-Naeini, R; Stachniak, TJ; Trudel, E | 1 |
| Berkó, A; László, F; László, FA; Molnár, AH; Párducz, A; Rojik, I; Varga, C | 1 |
| Funayama, H; Ishikawa, SE; Kasono, K; Saito, T | 1 |
| Doi, K; Kakigi, A; Nishimura, M; Okada, T; Takeda, T | 1 |
| Heinemann, A; Lippe, IT; Schuligoi, R; Stauber, RE | 1 |
| Bradesi, S; Lao, L; Larsson, H; Martinez, V; Mayer, EA | 1 |
| Cheng, L; Guo, F; Jing, W; Qi, JS; Zhang, JF | 1 |
| Branco, LG; Oliveira-Pelegrin, GR; Ravanelli, MI; Rocha, MJ | 1 |
| Carreño, FR; Cunningham, JT; Ji, LL | 1 |
| Bein, B; Cavus, E; Doerges, V; Hugo, HH; Meybohm, P; Nordstroem, J; Scholz, J; Steinfath, M | 1 |
| Athayde, LA; Faccioli, LH; Nomizo, A; Oliveira-Pelegrin, GR; Rocha, MJ | 1 |
| Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N | 1 |
| Arima, H; Hayashi, M; Hiroi, M; Kinoshita, N; Morishita, Y; Nagasaki, H; Oiso, Y; Ozaki, N; Shiota, A; Ueda, M | 1 |
| Bevilacqua, S; Ciappi, F; Dini, D; Gelsomino, S; Lazzeri, C; Peris, A; Romagnoli, S; Romano, SM | 1 |
| Kasai, T; Shimizu, F; Takamata, A | 1 |
| Dóczi, T; Pál, J; Steier, R; Sulyok, E; Vajda, Z | 1 |
| Asfar, P; Calzia, E; Georgieff, M; Giudici, R; Gröger, M; Hauser, B; Laporte, R; Möller, P; Ploner, F; Radermacher, P; Scheuerle, A; Simon, F; Vogt, JA; Wachter, U | 1 |
| Ducsay, CA; Hanson, K; Hyatt, K; Kaushal, KM; Mlynarczyk, M; Myers, DA | 1 |
| Hasibeder, W; Hausdorfer, H; Hengl, C; Knotzer, H; Maier, S; Pajk, W; Ulmer, H; Wurzinger, B | 1 |
| Dawe, KL; Fulford, AJ; Jessop, DS; Leggett, JD | 1 |
| de Winter, RF; Goekoop, JG; van Kempen, GM; Wiegant, VM; Wolterbeek, R | 1 |
| Pak, TR; Przybycien-Szymanska, MM; Rao, YS | 1 |
| Annane, D; Barrett, L; Blanchard, A; Brouland, JP; de la Grandmaison, GL; Gray, F; Guidoux, C; Mattot, V; Polito, A; Sharshar, T; Siami, S; Singer, M; Sonneville, R; Viltart, O | 1 |
| Lovejoy, DA; Rotzinger, S; Tan, LA | 1 |
| Osako, Y; Tanaka, K; Yuri, K | 1 |
| Harbich, D; Holsboer, F; Liebl, C; Mayer, B; Müller, MB; Scharf, SH; Schmidt, MV | 1 |
| Daicho, T; Hosoda, C; Nasa, Y; Oikawa, R; Takagi, N; Takeo, S; Tanonaka, K; Tanoue, A; Tsujimoto, G | 1 |
| Bigger, BW; Canal, MM; Cooper, JD; Wilkinson, FL; Wraith, JE; Wynn, R | 1 |
| Boullin, JP; Cleal, JK; Green, LR; Hanson, MA; Newman, JP; Noakes, DE; Poore, KR | 1 |
| Chang, CC; Chen, YC; Huang, HC; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Clarke, G; Cryan, JF; Desbonnet, L; Dinan, TG; Garrett, L; Kiely, B | 1 |
| Cunningham, JT; Ji, LL; Knight, WD; Little, JT | 1 |
| Fenton, RA; Hammond, HK; Insel, PA; Murray, F; Rieg, T; Schroth, J; Tang, T; Vallon, V | 1 |
| Ertmer, C; Lange, M; Morelli, A; Rehberg, S; Schneider, M; Traber, DL; Van Aken, H; Vincent, JL; Westphal, M | 1 |
| Dünser, M; Ertmer, C; Kampmeier, TG; Lange, M; Lipke, E; Morelli, A; Rehberg, S; Strohhäcker, AK; Traber, DL; Van Aken, H; Westphal, M; Whorton, E | 1 |
| Cox, RA; Enkhbaatar, P; Hawkins, H; Maybauer, DM; Maybauer, MO; Morita, N; Rehberg, S; Schmalstieg, FC; Traber, DL; Traber, LD; Westphal, M; Westphal-Varghese, BB; Whorton, E | 1 |
| Landry, DW; Oliver, JA | 1 |
| Dünser, MW | 1 |
| Booke, M | 1 |
| Braida, D; Bulgheroni, E; Busnelli, M; Capurro, V; Chini, B; Donzelli, A; Finardi, A; Lentini, D; Nishimori, K; Parenti, M; Parolaro, D; Pattini, L; Rubino, T; Sala, M | 1 |
| Gálfi, M; Hausinger, P; Juhász, A; Julesz, J; László, FA; László, M; Nagyéri, G; Ocskó, T; Pálföldi, R; Radács, M; Valkusz, Z | 1 |
| Yan, L | 1 |
| Fernandez, AA; Gosselink, KL; Zavala, JK | 1 |
| Foroutan, S; O'Donnell, ME; Wallace, BK | 1 |
| Carai, MA; Colombo, G; Gessa, GL; Ho, A; Kreek, MJ; Zhou, Y | 1 |
| Kou, J; Peng, D; Tao, C; Xu, F; Yin, D; Yu, B; Zhu, D | 1 |
| Lekic, T; Manaenko, A; Tang, J; Zhang, JH | 1 |
| Chang, CC; Chuang, CL; Huang, HC; Huo, TI; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Molina, PE; Sulzer, JK; Whitaker, AM | 1 |
| Brønd, L; Christensen, S; Jonassen, TE; Nielsen, JB; Nielsen, S; Torp, M | 1 |
| Nakamura, N | 1 |
| Annane, D; Barrett, L; Brouland, JP; Chrétien, F; Gray, F; Guidoux, C; Lorin de la Grandmaison, G; Mattot, V; Polito, A; Sharshar, T; Siami, S; Singer, M; Sonneville, R; Viltart, O | 1 |
| Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y | 1 |
| Butler, R; Chesham, JE; Davies, KE; Edwards, B; Fisher, SP; Foster, RG; Godinho, SI; Hastings, MH; Lee, S; Livieratos, A; Maywood, ES; Oliver, PL; Oster, H; Peirson, SN; Smith, JW; Sobczyk, MV; Wulff, K | 1 |
| Buchfelder, M; Kleindienst, A; Linde, L; Schlaffer, SM; Sharma, N; Verbalis, JG | 1 |
| Hernández, VS; Irles, C; Liu, B; Medina, MP; Morales, M; Nava-Kopp, AT; Zhang, L | 1 |
| Akahoshi, Y; Fujiki, H; Iwanaga, Y; Miyazaki, S; Morooka, H; Nakano, Y; Takase, T; Tamaki, Y | 1 |
| Asakawa, A; Ataka, K; Fujimiya, M; Inui, A; Nagaishi, K | 1 |
| Bartha, E; Cox, RA; Enkhbaatar, P; Hasselbach, AK; Jonkam, C; Rehberg, S; Sousse, L; Traber, DL; Traber, LD; Westphal, M; Yamamoto, Y | 1 |
| Brueggemann, LI; Byron, KL; Kumar, L; Mani, BK; O'Dowd, J; Ross, M | 1 |
| Charney, DR; Cornwell, B; Ernst, M; Grillon, C; Krimsky, M; Vytal, K | 1 |
| Aro, J; Ilves, M; Koivisto, E; Ronkainen, VP; Ruskoaho, H; Rysä, J; Szokodi, I; Tenhunen, O; Tokola, H | 1 |
| Fujisawa, M; Koike, H; Matsuoka, Y; Ueno, K; Yorikane, R | 1 |
| Fenton, RA; Moeller, HB; Rittig, S | 1 |
| Gaburro, S; Kuzdas, D; Singewald, N; Stefanova, N; Stemberger, S; Wenning, GK | 1 |
| Chen, WW; Sun, HJ; Wang, JJ; Xiong, XQ; Zhang, F; Zhou, YB; Zhu, GQ | 1 |
| Ferguson, JN; Pitkow, LJ; Young, LJ | 1 |
| Asano, Y; Homma, S; Kusano, E; Makino, S; Matsuo, Y; Nakamura, M; Oohara, T; Shimizu, T; Takeda, S | 1 |
| Gulec, G; Noyan, B | 1 |
| Landgraf, R | 1 |
| Ball, C; Bone, HG; Borgulya, R; Sielenkämper, AW; Stubbe, H; Van Aken, H; Westphal, M | 1 |
| Campbell, IC; Connan, F; Katzman, M; Lightman, SL; Treasure, J | 1 |
| Ito, M; Jameson, JL; Martinson, FA; Russell, TA; Weiss, J; Yu, RN | 1 |
| Hanazono, Y; Honda, K; Ideno, J; Ishibashi, S; Kume, A; Mizukami, H; Okada, T; Ozawa, K; Saito, T | 1 |
| Bone, HG; Freise, H; Kehrel, BE; Sielenkämper, AW; Van Aken, H; Westphal, M | 1 |
| Ji, X; Kurahashi, K; Murakami, S; Nishihashi, T; Trandafir, CC; Wang, A | 1 |
| Fujimoto, N; Matsumoto, T; Mineta, K; Nomura, M; Sasaguri, T; Terado, M; Ueta, Y | 1 |
| Keshavan, V; Shanthi, M; Tyagi, MG; Vikram, GS | 1 |
| De Nicola, AF; Lima, A; Pietranera, L; Roig, P; Saravia, F | 1 |
| Bond, GR; Johnson, SB; Sztajnkrycer, MD; Weaver, AL | 1 |
| Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sato, A; Satomi, S; Suzuki, K; Suzuki, M; Yanagisawa, T | 1 |
| Berg, RA; Butman, SM; Ewy, GA; Hilwig, RW; Kern, KB; Lindner, KH; Schwarzacher, S; Wenzel, V | 1 |
| Gross, KW; Hallas, BH; Horowitz, JM; Meeder, BA; Torres, G | 1 |
| Cheng, Y; Jiang, Q; Ma, CG; Ming, L; Zhou, LL | 1 |
| Rojiani, AM; Schroeder, BM; Silver, SM; Sterns, RH | 1 |
| Dünser, MW; Lindner, KH; Wenzel, V | 1 |
| Bello, G; de Talancé, N; Dewachter, P; Jouan-Hureaux, V; Lartaud, I; Longrois, D; Mertes, PM | 1 |
| Chodobski, A | 1 |
| Chen, JM; Lin, BC; Liu, WY; Song, CY; Wang, CH; Yang, J | 1 |
| Bein, B; Brand, PA; Cavus, E; Dörges, V; Meybohm, P; Scholz, J; Steinfath, M | 1 |
| Chang, CC; Chang, FY; Chen, YC; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K | 1 |
| Chodobski, A; Pascale, CL; Sarri, JE; Szmydynger-Chodobska, J | 1 |
| Aoyagi, T; Hiroyama, M; Oikawa, R; Sanbe, A; Takeo, S; Tanoue, A; Wang, S | 1 |
| Anderson, WP; Edgley, AJ; Evans, RG; Gao, Y; Shweta, A | 1 |
| Bosch, OJ; Bredewold, R; Müsch, W; Neumann, ID; Slattery, DA | 1 |
| Barbosa, MA; Chan, DM; Chen, PC; Cheung, AT; Driessen, B; Gunther, RA; Jahr, JS; Ramanujam, S; To, PL | 1 |
| Bergmann, A; Christ-Crain, M; Morgenthaler, NG; Müller, B; Redl, H; Struck, J | 1 |
| Anisman, H; Merali, Z; Poulter, MO; Prakash, P | 1 |
| Feifel, D; Melendez, G; Priebe, K; Shilling, PD | 1 |
| Boston, RA; Burns, PM; Cheung, AT; Driessen, B; Gunther, RA; Jahr, JS; Lamb, SV; Vincent, SE; Zarucco, L | 1 |
| Dong, H; Fan, YH; Wang, HC; Yang, XD; Zhao, LY; Zheng, QS | 1 |
| Cavus, E; Dünser, MW; Jochberger, S; Krismer, AC; Lindner, KH; Mayr, VD; Müller, TH; Raab, H; Schwarzacher, S; Stadlbauer, KH; Wagner-Berger, HG; Wenzel, V | 1 |
| Chang, CC; Chang, FY; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Bein, B; Cavus, E; Dörges, V; Meybohm, P; Scholz, J; Stadlbauer, KH; Steffen, M; Weber, B; Wenzel, V | 1 |
| Baile, CA; Choi, YH; Della-Fera, MA; Duan, J; Hamrick, M; Hartzell, D | 1 |
| Dohi, S; Fukuoka, N; Iida, H; Iida, M; Kumazawa, M; Michino, T; Takenaka, M; Uchida, M | 1 |
| Li, T; Liu, LM; Ming, J; Xu, J; Yang, GM | 1 |
| Balavoine, F; Bodineau, L; Fassot, C; Frugière, A; Inguimbert, N; Llorens-Cortes, C; Marc, Y; Roques, B | 1 |
| Faivre, V; Kopel, T; Losser, MR; Payen, D | 1 |
| Bichet, DG; Schrier, RW | 1 |
| Verbalis, JG | 1 |
| Baláspiri, L; Csáti, S; László, FA; Manning, M | 1 |
| Gellai, M | 1 |
| Edwards, BR | 1 |
| DeFronzo, RA; Forrest, JN; Mandell, IN; Robertson, GL | 1 |
| Cox, AT; Gunther, RA; Ho, HS | 1 |
| Ichikawa, M; Kumagai, H; Kumagai, K; Nishizawa, M; Ryuzaki, M; Saruta, T; Suzuki, H | 1 |
| Karácsony, G; László, F; László, FA; Pávó, I; Rojik, I; Varga, C | 1 |
| Bo, J; Bukoski, RD; Li, J | 1 |
| Ichikawa, M; Jimbo, M; Kumagai, H; Matsumura, Y; Ryuzaki, M; Saruta, T; Suzuki, H | 1 |
| Chiba, K; Fukuzawa, A; Ishigai, Y; Mori, T; Shibano, T | 1 |
| Kim, P; Kirino, T; Kobayashi, E; Mori, T; Nagata, K; Nikaido, H; Sasaki, T | 1 |
| Karaki, H; Kunieda, T; Mitsui-Saito, M; Oda, K; Okada, T; Ozaki, T; Takimoto, M | 1 |
| Chang, Q; Conway, RS; Natelson, BH; Ottenweller, JE | 1 |
| Vaziri, ND; Wang, ZQ | 1 |
| Carney, SL; Gillies, AH; Ray, C | 1 |
| Charles, CJ; Donald, RA; Ikram, H; Prickett, T; Richards, AM; Rogers, SJ | 1 |
| Hanley, MR | 1 |
| Fassett, RG; Schrier, RW | 1 |
| Hamanaka, K; Kitayama, I; Nakase, S; Nomura, J; Soya, H | 1 |
| Bailly, C; Bens, M; De Jesus Ferreira, MC; Guinamard, R; Marvão, P; Moreau, R; Paulais, M; Teulon, J; Vandewalle, A | 1 |
| Bankir, L; Bouby, N; Hassler, C | 1 |
| González de Aguilar, JL; Gordon, JW; Kienlen-Campard, P; Loeffler, JP; Lutz-Bucher, B; René, F | 1 |
| Keil, LC; Thrasher, TN | 1 |
| Dakine, N; Grino, M; Oliver, C | 1 |
| Bolognani, F; Goya, RG | 1 |
| Dapzol, J; Girod, V; Grélot, L; Maffrand, JP; Serradeil-Le Gal, C | 1 |
| Wood, CE | 1 |
| Ferguson, M; Mayberg, M; McQuarrie, DG; Shons, A | 1 |
| Iasnetsov, VV; Shashkov, VS | 1 |
| Atanasova, I; Girchev, R; Krusteva, S; Mikhov, D; Natcheff, N; Schmausser, U; Thurau, K | 1 |
| Johnston, CI; Phillips, PA; Risvanis, J; Stephenson, JM; Trinder, D | 1 |
| Chalmers, J; Lightman, SL; Noble, MI; Pate, P; Song, G; Sutton, R; Travill, CM; Williams, TD | 1 |
| Arnolda, L; Johnston, CI; McGrath, BP | 1 |
| Bernath, GA; Cogswell, TL; Klopfenstein, HS; Mathias, DW | 1 |
| James, LS; Kiu, GT; Moessinger, AC; Shen, CT | 1 |
| Gavras, H; Gavras, I | 1 |
| Bishop, A; Hanson, J; Hogan, B; Murphy, D; Murphy, MN; Polak, JM; Rindi, G; Stamp, GW | 1 |
| Bajorek, JG; Lee, RJ; Lomax, P | 1 |
| Fejes-Tóth, G; Filep, J | 1 |
| Brosnihan, KB; Ferrario, CM; Saruta, T; Suzuki, H | 1 |
| Coe, JE; Ross, MJ | 1 |
| Larivière, R; Schiffrin, EL; St-Louis, J | 1 |
| Riegger, AJ | 1 |
| Ludbrook, J; Potocnik, SJ; Woods, RL | 1 |
| Albrightson, CR; Brooks, DP; Huffman, WF; Kinter, LB; Koster, PF; Stassen, FL; Wasserman, MA | 1 |
| Arbab, MA; Delgado, TJ; Svendgaard, NA; Warberg, J | 1 |
| Baláspiri, L; László, FA | 1 |
| Karácsony, G; Karcsú, S; Kocsis, J; László, FA | 1 |
| Balaban, CD; Barbella, YR; Dundore, RL; Keil, LC; Severs, WB; Wurpel, JN | 1 |
| Di Pette, D; Watson, AJ | 1 |
16 review(s) available for arginine vasopressin and Disease Models, Animal
| Article | Year |
|---|---|
The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder.
Topics: Animals; Arginine Vasopressin; Autism Spectrum Disorder; Disease Models, Animal; Humans; Interpersonal Relations; Oxytocin; Social Behavior | 2017 |
Of Mice and Men-The Physiology, Psychology, and Pathology of Overhydration.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Brain; Cognition; Disease Models, Animal; Drinking; Female; Humans; Male; Mice; Organism Hydration Status; Polydipsia; Signal Transduction; Urination; Volition; Water Intoxication; Water-Electrolyte Balance | 2019 |
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
Involvement of ENaC in the development of salt-sensitive hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; EGF Family of Proteins; Epithelial Cells; Epithelial Sodium Channels; Humans; Hypertension; Hypoglycemic Agents; Molecular Targeted Therapy; Nephrons; Oxidative Stress; Rats, Inbred Dahl; Renal Reabsorption; Renin-Angiotensin System; Signal Transduction; Sodium Chloride, Dietary | 2017 |
Behavioral effects of neuropeptides in rodent models of depression and anxiety.
Topics: Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Cholecystokinin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Galanin; Humans; MSH Release-Inhibiting Hormone; Neuropeptide Y; Neuropeptides; Neuropsychological Tests; Oxytocin; Social Behavior; Urocortins | 2010 |
Increased complexity of vasopressin's vascular actions.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Disease Models, Animal; Female; Receptors, Vasopressin; Shock, Septic | 2010 |
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Humans; Mutation; Rats; Receptors, Vasopressin | 2013 |
Neuropeptides and social behavior: animal models relevant to autism.
Topics: Amygdala; Animals; Arginine Vasopressin; Arvicolinae; Brain Chemistry; Disease Models, Animal; Female; Genes, fos; Humans; Male; Mice; Mice, Knockout; Mice, Transgenic; Neuropeptides; Olfactory Pathways; Oxytocin; Pair Bond; Prosopagnosia; Receptors, Vasopressin; Recognition, Psychology; Social Behavior | 2002 |
Role of vasopressin in cardiac, pulmonary, hepatic, and adrenal disorders.
Topics: Acidosis, Respiratory; Adrenal Insufficiency; Animals; Arginine Vasopressin; Body Water; Constriction, Pathologic; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glucocorticoids; Heart Diseases; Humans; Hypercapnia; Hypoxia; Liver Cirrhosis; Mineralocorticoids; Norepinephrine; Rats; Respiratory Insufficiency; Vena Cava, Inferior | 1984 |
The role of vasopressin in the control of renal hemodynamics. The Brattleboro rat as an experimental model.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus; Disease Models, Animal; Diuresis; Glomerular Filtration Rate; Hemodynamics; Kidney; Oxytocin; Rats; Rats, Brattleboro; Rats, Mutant Strains; Renal Circulation; Vascular Resistance; Vasopressins | 1982 |
Water balance in the Brattleboro rat: single or multiple defects?
Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus; Disease Models, Animal; Glomerular Filtration Rate; Glycosaminoglycans; Kidney; Kidney Concentrating Ability; Kidney Medulla; Loop of Henle; Nephrons; Osmolar Concentration; Prostaglandins; Rats; Rats, Brattleboro; Rats, Mutant Strains; Vasopressins; Water-Electrolyte Imbalance | 1982 |
A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome.
Topics: Aldosterone; Animals; Arginine Vasopressin; Disease Models, Animal; Edema; Humans; Models, Biological; Nephrotic Syndrome; Plasma Volume; Renin-Angiotensin System; Sodium; Sympathetic Nervous System; Water-Electrolyte Imbalance | 1998 |
Gene therapy in the neuroendocrine system: its implementation in experimental models using viral vectors.
Topics: Adenoviridae; Animals; Arginine Vasopressin; Diabetes Insipidus; Disease Models, Animal; Gene Transfer, Horizontal; Genes, Retinoblastoma; Genetic Therapy; Genetic Vectors; Herpesvirus 1, Human; Humans; Hypothalamic Diseases; Neurosecretory Systems; Pituitary Neoplasms; Thymidine Kinase | 2001 |
[Neurochemical mechanisms of the development of motion sickness].
Topics: Animals; Arginine Vasopressin; Biogenic Amines; Cats; Disease Models, Animal; gamma-Aminobutyric Acid; Male; Models, Neurological; Motion Sickness; Scopolamine; Vestibular Nerve; Vestibular Nuclei; Vestibule, Labyrinth | 1992 |
Salt-induced hypertension: the interactive role of vasopressin and of the sympathetic nervous system.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Hypertension; Rats; Sodium Chloride; Sympathetic Nervous System | 1989 |
Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Biomechanical Phenomena; Disease Models, Animal; Endorphins; Epilepsy; Humans; Nerve Tissue Proteins; Neurology; Somatostatin; Thyrotropin-Releasing Hormone | 1986 |
5 trial(s) available for arginine vasopressin and Disease Models, Animal
| Article | Year |
|---|---|
Chronic social stress during adolescence: interplay of paroxetine treatment and ageing.
Topics: Adrenal Glands; Aging; Animals; Arginine Vasopressin; Body Weight; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Longitudinal Studies; Male; Mice; Paroxetine; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Social Isolation; Stress, Psychological; Thymus Gland | 2013 |
Arginine Vasopressin and Arginine Vasopressin Receptor 1b Involved in Electroacupuncture-Attenuated Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Hepatectomy Rats.
Topics: Acupuncture Points; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Arginine Vasopressin; Corticosterone; Disease Models, Animal; Electroacupuncture; Gene Expression Regulation; Hepatectomy; Hyperkinesis; Hypothalamo-Hypophyseal System; Mice; Neuropeptides; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Vasopressin; RNA, Messenger; Signal Transduction | 2016 |
A novel chronic social stress paradigm in female mice.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Arginine Vasopressin; Body Weight; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Feeding Behavior; Female; Gene Expression; Hierarchy, Social; In Situ Hybridization; Male; Mice; Motor Activity; Organ Size; Receptors, Gonadotropin; Sex Characteristics; Social Environment; Stress, Psychological | 2010 |
Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Disease Models, Animal; Female; Receptors, Vasopressin; Sheep; Shock, Septic | 2010 |
Oxytocin increases anxiety to unpredictable threat.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents; Anxiety; Arginine Vasopressin; Cross-Sectional Studies; Disease Models, Animal; Double-Blind Method; Electroshock; Female; Humans; Male; Oxytocin; Predictive Value of Tests; Septal Nuclei | 2013 |
218 other study(ies) available for arginine vasopressin and Disease Models, Animal
| Article | Year |
|---|---|
Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors.
Topics: ADP-ribosyl Cyclase 1; Animals; Autism Spectrum Disorder; Behavior, Animal; Calcium; Disease Models, Animal; Female; HEK293 Cells; Humans; Male; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Mice, Knockout; Oxytocin; Receptors, Oxytocin; Social Behavior | 2019 |
Hemodynamic phenotyping of transgenic rats with ubiquitous expression of an angiotensin-(1-7)-producing fusion protein.
Topics: Angiotensin I; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Flow Velocity; Blood Pressure; Cardiovascular System; Disease Models, Animal; Genotype; Glial Fibrillary Acidic Protein; Hemodynamics; Hypertension; Male; Peptide Fragments; Phenotype; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Fusion Proteins; Regional Blood Flow; Sympathetic Nervous System; Time Factors; Vascular Resistance | 2021 |
Recovery from Liver Failure and Fibrosis in a Rat Portacaval Anastomosis Model after Neurointermediate Pituitary Lobectomy.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Humans; Hypophysectomy; Liver Cirrhosis; Liver Failure; Male; Pituitary Gland; Portacaval Shunt, Surgical; Rats; Rats, Wistar; Receptors, Vasopressin; Signal Transduction | 2021 |
AVP-eGFP was significantly upregulated by hypovolemia in the parvocellular division of the paraventricular nucleus in the transgenic rats.
Topics: Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Genes, Reporter; Green Fluorescent Proteins; Hypothalamo-Hypophyseal System; Hypovolemia; Injections, Intraperitoneal; Male; Paraventricular Hypothalamic Nucleus; Polyethylene Glycols; Proto-Oncogene Proteins c-fos; Rats, Transgenic; Rats, Wistar; Saline Solution, Hypertonic; Supraoptic Nucleus; Time Factors; Up-Regulation | 2022 |
The live biotherapeutic Blautia stercoris MRx0006 attenuates social deficits, repetitive behaviour, and anxiety-like behaviour in a mouse model relevant to autism.
Topics: Animals; Anxiety; Arginine Vasopressin; Autism Spectrum Disorder; Autistic Disorder; Clostridiales; Disease Models, Animal; Mice; Mice, Inbred Strains; Oxytocin; RNA, Messenger | 2022 |
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling | 2022 |
Effects of arginine vasopressin on the transcriptome of prefrontal cortex in autistic rat model.
Topics: Animals; Arginine Vasopressin; Autistic Disorder; Disease Models, Animal; Prefrontal Cortex; Rats; Transcriptome; Valproic Acid | 2022 |
AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Arginine Vasopressin; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments | 2020 |
Childhood stress impairs social function through AVP-dependent mechanisms.
Topics: Adult; Adverse Childhood Experiences; Aged; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Behavior, Animal; Borderline Personality Disorder; Disease Models, Animal; Female; Humans; Indoles; Male; Middle Aged; Neurophysins; Paraventricular Hypothalamic Nucleus; Protein Precursors; Pyrrolidines; Rats; Sexual Maturation; Social Behavior; Stress, Psychological; Supraoptic Nucleus; Vasopressins; Young Adult | 2019 |
Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats.
Topics: Animals; Arginine Vasopressin; Arterial Pressure; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Heart Rate; Hypertension; Injections, Intravenous; Male; Microinjections; Norepinephrine; Paraventricular Hypothalamic Nucleus; Peptide Hormones; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Sympathetic Nervous System | 2020 |
Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Arginine Vasopressin; Biological Transport; Blood-Brain Barrier; Cell Membrane Permeability; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Rats; Rats, Inbred Lew; Receptors, Vasopressin | 2020 |
Aquaporin-2 expression in the kidney and urine is elevated in rats with monocrotaline-induced pulmonary heart disease.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Biomarkers; Disease Models, Animal; Humans; Hypertension, Pulmonary; Kidney; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Renal Elimination | 2020 |
Plasma vasopressin levels are closely associated with fetal hypotension and neuronal injury after hypoxia-ischemia in near-term fetal sheep.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Biomarkers; Blood Gas Analysis; Disease Models, Animal; Female; Fetal Hypoxia; Hydrogen-Ion Concentration; Hypotension; Hypoxia-Ischemia, Brain; Male; Nervous System Diseases; Neurons; Sheep; Umbilical Cord; Vasopressins | 2020 |
Effects of neural estrogen receptor beta deletion on social and mood-related behaviors and underlying mechanisms in male mice.
Topics: Affect; Aggression; Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Humans; Locomotion; Male; Mice; Mice, Knockout; Mutation; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Septal Nuclei; Signal Transduction; Testosterone | 2020 |
Sex Differences in the Regulation of Vasopressin and Oxytocin Secretion in Bile Duct-Ligated Rats.
Topics: Animals; Arginine Vasopressin; Bile Ducts; Dehydroepiandrosterone; Disease Models, Animal; Estradiol; Female; Glycopeptides; Hyponatremia; Ligation; Male; Ovariectomy; Oxytocin; Rats; Rats, Sprague-Dawley; Sex Characteristics; Sex Factors; Supraoptic Nucleus; Testosterone | 2021 |
Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.
Topics: Animals; Aquaporin 2; Aquaporin 3; Arginine Vasopressin; Biomarkers; Dexamethasone; Disease Models, Animal; Diuretics; Down-Regulation; Epithelial Sodium Channels; Glucocorticoids; Heart Failure; Hyponatremia; Immediate-Early Proteins; Kidney Tubules, Collecting; Male; Protein Serine-Threonine Kinases; Rats, Wistar; Receptors, Vasopressin; Signal Transduction; Sodium; Sodium-Potassium-Chloride Symporters; Water-Electrolyte Balance | 2020 |
Compromised regulation of the rat brain parenchymal arterioles in vasopressin-associated acute hyponatremia.
Topics: Acidosis; Acute Disease; Adenosine Triphosphate; Animals; Arginine Vasopressin; Arterioles; Brain; Disease Models, Animal; Humans; Hyponatremia; In Vitro Techniques; Male; Middle Cerebral Artery; Nitric Oxide Donors; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Vasoconstriction | 2020 |
Male-specific features are reduced in Mecp2-null mice: analyses of vasopressinergic innervation, pheromone production and social behaviour.
Topics: Aggression; Animals; Arginine Vasopressin; Behavior, Animal; Brain; Disease Models, Animal; Female; Intercellular Signaling Peptides and Proteins; Male; Methyl-CpG-Binding Protein 2; Mice; Mice, Knockout; Oxytocin; Pheromones; Sex Characteristics; Sex Differentiation; Social Behavior | 2020 |
The neurohypophysial oxytocin and arginine vasopressin system is activated in a knee osteoarthritis rat model.
Topics: Animals; Arginine Vasopressin; Arthralgia; Disease Models, Animal; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Neurons; Nociception; Osteoarthritis, Knee; Oxytocin; Rats; Rats, Transgenic; Rats, Wistar | 2020 |
Protective effect of microinjection of glutamate into hypothalamus paraventricular nucleus on chronic visceral hypersensitivity in rats.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Glutamic Acid; Hyperalgesia; Kainic Acid; Male; Microinjections; Pain Threshold; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Vagus Nerve; Visceral Pain | 2020 |
Oestrogen inhibits salt-dependent hypertension by suppressing GABAergic excitation in magnocellular AVP neurons.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Basal Nucleus of Meynert; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Estradiol; Female; GABAergic Neurons; Hypertension; Male; Nephrectomy; Ovariectomy; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Solute Carrier Family 12, Member 2; Symporters; Vasoconstriction | 2021 |
Caffeine-related effects on cognitive performance: Roles of apoptosis in rat hippocampus following sleep deprivation.
Topics: Animals; Apoptosis; Arginine Vasopressin; Caffeine; Central Nervous System Stimulants; Cognition; Cognitive Dysfunction; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Humans; Male; Mitochondria; Motor Activity; Nootropic Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Signal Transduction; Sleep Deprivation; Spatial Learning; Vasoactive Intestinal Peptide | 2021 |
Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model.
Topics: Adolescent; Animals; Arginine Vasopressin; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Female; Humans; Neurophysins; Paraventricular Hypothalamic Nucleus; Pregnancy; Prenatal Exposure Delayed Effects; Protein Precursors; Rats; Social Behavior; Stereotyped Behavior; Valproic Acid; Vasopressins | 2021 |
A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia.
Topics: Amino Acid Sequence; Animals; Apelin; Apelin Receptors; Arginine Vasopressin; Blood Glucose; Blood Pressure; Cell Line; Colforsin; Cyclic AMP; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Electrolytes; Half-Life; Hyponatremia; Kidney Tubules, Collecting; Male; Mice; Models, Biological; Myocardial Contraction; Peptides; Phosphorylation; Rats, Sprague-Dawley; Tolvaptan | 2021 |
Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Extracorporeal Membrane Oxygenation; Heart Arrest; Male; Norepinephrine; Resuscitation; Shock, Cardiogenic; Swine; Vasoconstrictor Agents | 2021 |
Is PTSD-Phenotype Associated with HPA-Axis Sensitivity? Feedback Inhibition and Other Modulating Factors of Glucocorticoid Signaling Dynamics.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Brain; Corticosterone; Disease Models, Animal; Humans; Methylprednisolone; Pituitary-Adrenal System; Psychological Distress; Rats; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Stress Disorders, Post-Traumatic; Tacrolimus Binding Proteins | 2021 |
Effects of Arginine Vasopressin and V1 Receptor Antagonist on Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage: An Experimental Study.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Basilar Artery; Disease Models, Animal; Male; Rabbits; Random Allocation; Receptors, Vasopressin; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2018 |
Acute hypoxia activates neuroendocrine, but not presympathetic, neurons in the paraventricular nucleus of the hypothalamus: differential role of nitric oxide.
Topics: Acute Disease; Adrenergic Fibers; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Disease Models, Animal; Ependymoglial Cells; Hypoxia; Male; Neural Inhibition; Neuroendocrine Cells; Nitrergic Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Paraventricular Hypothalamic Nucleus; Phenotype; Rats, Sprague-Dawley; Vimentin | 2017 |
Arginine vasopressin relates with spatial learning and memory in a mouse model of spinocerebellar ataxia type 3.
Topics: Animals; Arginine Vasopressin; Brain; Disease Models, Animal; Machado-Joseph Disease; Male; Mice; Spatial Learning; Spatial Memory | 2017 |
[Influence of Electroacupuncture Stimulation with Different Intensities and Therapeutic Intervals on Learning-memory Ability and Expression of Aβ 1-40 and Arginine Vasopressin Genes in the Hippocampal CA 1 Region in VD Rats].
Topics: Acupuncture Points; Amyloid beta-Peptides; Animals; Arginine Vasopressin; CA1 Region, Hippocampal; Dementia, Vascular; Disease Models, Animal; Electroacupuncture; Humans; Learning; Male; Memory; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2017 |
Effect of Endogenous Arginine-Vasopressin Arising from the Paraventricular Nucleus on Learning and Memory Functions in Vascular Dementia Model Rats.
Topics: Animals; Arginine Vasopressin; Brain Ischemia; Corticotropin-Releasing Hormone; Dementia, Vascular; Disease Models, Animal; Hippocampus; Humans; Learning; Memory; Neurons; Paraventricular Hypothalamic Nucleus; Rats | 2017 |
Arginine Vasopressin-Aquaporin-2 Pathway-Mediated Dehydration Effects of Electroacupuncture in Guinea Pig Model of AVP-Induced Eendolymphatic Hydrops.
Topics: Acupuncture Points; Animals; Aquaporin 2; Arginine Vasopressin; Dehydration; Disease Models, Animal; Electroacupuncture; Endolymphatic Hydrops; Guinea Pigs | 2019 |
Effects of Clonidine on the Cardiovascular, Renal, and Inflammatory Responses to Experimental Bacteremia.
Topics: Acute Kidney Injury; Animals; Arginine Vasopressin; Bacteremia; Cardiac Output; Clonidine; Disease Models, Animal; Female; Heart Rate; Hypotension; Kidney; Sheep; Vasodilation | 2019 |
AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
Topics: A Kinase Anchor Proteins; Amino Acid Sequence; Animals; Aquaporin 2; Arginine Vasopressin; Benzazepines; Benzhydryl Compounds; Cell Line, Transformed; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Epithelial Cells; Gene Expression Regulation; Humans; Kidney Tubules, Collecting; Male; Mice, Inbred C57BL; Osmolar Concentration; Phenols; Protein Binding; Receptors, Vasopressin; Tolvaptan; Water | 2018 |
A rat model for pituitary stalk electric lesion-induced central diabetes insipidus: application of 3D printing and further outcome assessments.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Magnetic Resonance Imaging; Male; Pituitary Gland; Printing, Three-Dimensional; Rats, Sprague-Dawley; Severity of Illness Index | 2018 |
Chemical chaperone 4-phenylbutylate reduces mutant protein accumulation in the endoplasmic reticulum of arginine vasopressin neurons in a mouse model for familial neurohypophysial diabetes insipidus.
Topics: Animals; Arginine Vasopressin; Butylamines; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons | 2018 |
Endoplasmic reticulum stress induces apoptosis of arginine vasopressin neurons in central diabetes insipidus via PI3K/Akt pathway.
Topics: Acetylcysteine; Animals; Apoptosis; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum Stress; Hypothalamus; Male; MAP Kinase Signaling System; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats, Sprague-Dawley | 2019 |
Function of the hypothalamo-neurohypophysial system in rats with myocardial infarction is modified by melatonin.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Feedback, Physiological; Hypothalamo-Hypophyseal System; Male; Melatonin; Myocardial Infarction; Oxytocin; Pineal Gland; Radioimmunoassay; Rats; Rats, Wistar | 2012 |
Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
Topics: Action Potentials; Analgesics; Animals; Arginine Vasopressin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperalgesia; Male; Nerve Fibers, Unmyelinated; Neurons; Oxytocin; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Spinal Cord; Swimming | 2013 |
Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Behavior, Animal; Corticotropin-Releasing Hormone; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Hypothalamus; Male; Morphine; Morphine Dependence; Neuropeptides; Pro-Opiomelanocortin; Rats; Rats, Wistar; Stress, Physiological; Urocortins | 2013 |
Diabetes diminishes the portal-systemic collateral vascular response to vasopressin via vasopressin receptor and Gα proteins regulations in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Blood Glucose; Collateral Circulation; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; GTP-Binding Protein alpha Subunits; Hemodynamics; Hypertension, Portal; Liver Cirrhosis; Male; Rats; Receptors, Vasopressin | 2013 |
Androgen receptor deficiency alters the arginine-vasopressin sexually dimorphic system in Tfm rats.
Topics: Analysis of Variance; Androgen-Insensitivity Syndrome; Animals; Animals, Newborn; Arginine Vasopressin; Brain; Disease Models, Animal; Female; Male; Mutation; Neurons; Rats; Receptors, Androgen; Sex Characteristics | 2013 |
Congestive heart failure in rats is associated with increased collecting duct vasopressin sensitivity and vasopressin type 2 receptor reexternalization.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Cyclic AMP; Disease Models, Animal; Female; Heart Failure; Kidney Cortex; Kidney Tubules, Collecting; Rats; Rats, Wistar; Receptors, Vasopressin | 2013 |
Cellular bioenergetics changes in magnocellular neurons may affect copeptin expression in the late phase of sepsis.
Topics: Animals; Annexin A5; Arginine Vasopressin; Cecum; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Glycopeptides; Hypothalamus; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Neurons; Nitric Oxide Synthase Type II; Optic Chiasm; Rats; Rats, Wistar; Receptors, Interleukin-1 Type I; RNA, Messenger; Sepsis; Statistics, Nonparametric; Time Factors | 2014 |
Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arginine Vasopressin; Autophagy; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Hypothalamus; Inclusion Bodies; Mice; Models, Biological; Neurons; Phagosomes; Phenotype; Protein Aggregates; Sequestosome-1 Protein; Ubiquitinated Proteins; Water Deprivation | 2014 |
Social preference and maternal defeat-induced social avoidance in virgin female rats: sex differences in involvement of brain oxytocin and vasopressin.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Brain; Disease Models, Animal; Escape Reaction; Estrous Cycle; Female; Gene Expression Regulation; Male; Ornipressin; Oxytocin; Rats; Rats, Wistar; Sex Characteristics; Social Behavior; Stress, Psychological; Vasopressins | 2014 |
Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
Topics: Animals; Aquaporin 2; Aquaporin 3; Arginine Vasopressin; Biological Transport, Active; Body Water; Cell Membrane; Cell Polarity; Cells, Cultured; Collagen Type I; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Extracellular Matrix Proteins; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osmolar Concentration; Osmotic Pressure; Phosphorylation; Polyuria; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Receptors, Vasopressin; RNA Interference; RNA, Small Interfering | 2014 |
Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration.
Topics: Animals; Antineoplastic Agents; Arginine Vasopressin; Cisplatin; Creatinine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granulocytes; Hydrocortisone; Linear Models; Male; Nausea; Radioimmunoassay; Time Factors; Visual Analog Scale; Vomiting | 2014 |
Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure.
Topics: Administration, Oral; Animals; Aquaporin 2; Arginine Vasopressin; Chronic Disease; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Gene Expression Regulation; Heart Failure; Male; Myocardial Infarction; Plant Extracts; Poria; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Time Factors | 2014 |
Local overexpression of V1a-vasopressin receptor enhances regeneration in tumor necrosis factor-induced muscle atrophy.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscular Atrophy; Receptors, Vasopressin; Regeneration; Signal Transduction; Tumor Necrosis Factors | 2014 |
Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.
Topics: Adult; Animals; Arginine Vasopressin; Biomarkers; Blood Pressure; Disease Models, Animal; Early Diagnosis; Endothelium, Vascular; Female; Glycopeptides; Humans; Hypertension; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Pre-Eclampsia; Pregnancy; Proteinuria; ROC Curve; Time Factors; Vasopressins | 2014 |
Ghrelin effects expression of several genes associated with depression-like behavior.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Ghrelin; Interleukin-1beta; Mice; Olfactory Bulb; Receptors, LH; Receptors, Opioid; Serotonin Plasma Membrane Transport Proteins | 2015 |
Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Hypothalamus; Interleukin-1beta; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Receptors, Interleukin-1; Sepsis | 2015 |
Activation of ENaC by AVP contributes to the urinary concentrating mechanism and dilution of plasma.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Epithelial Sodium Channels; Homeostasis; Hypernatremia; Hyponatremia; Kidney; Mice, Inbred C57BL; Renin-Angiotensin System; Sodium | 2015 |
Prenatal hyperandrogenic environment induced autistic-like behavior in rat offspring.
Topics: Androgens; Animals; Arginine Vasopressin; Child Development Disorders, Pervasive; Disease Models, Animal; Estrous Cycle; Female; Letrozole; Male; Nitriles; Oxytocin; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Receptors, Vasopressin; RNA, Messenger; Sex Characteristics; Social Behavior; Sound; Testosterone; Triazoles; Vocalization, Animal | 2015 |
Effects of hydration in rats and mice with polycystic kidney disease.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Drinking; Hypodermoclysis; Kidney; Mice, Inbred C57BL; Mice, Transgenic; Polycystic Kidney Diseases; Rats; Receptors, Vasopressin | 2015 |
Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats.
Topics: Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Estrogen Receptor beta; Gene Expression; Hypothalamus; Male; Motor Activity; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Mineralocorticoid; RNA, Messenger; Tretinoin | 2015 |
Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Cyclic AMP-Dependent Protein Kinases; Diabetes Insipidus; Disease Models, Animal; Hypothalamus; Kidney; Mice; Mice, Transgenic; Phenotype; Receptors, Vasopressin; Water-Electrolyte Balance | 2015 |
The Vasopressin 1b Receptor Antagonist A-988315 Blocks Stress Effects on the Retrieval of Object-Recognition Memory.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticosterone; Disease Models, Animal; Exploratory Behavior; Humans; Male; Memory Disorders; Mental Recall; Piperazines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Receptors, Vasopressin; Recognition, Psychology; Stress, Psychological; Sulfonamides; Time Factors; Tritium | 2015 |
The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure.
Topics: Aldosterone; Animals; Arginine Vasopressin; Disease Models, Animal; Heart Failure; Male; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling | 2015 |
Salt-induced sympathoexcitation involves vasopressin V1a receptor activation in the paraventricular nucleus of the hypothalamus.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arterial Pressure; Disease Models, Animal; Hypertension; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Rats, Wistar; Receptors, Vasopressin; Sodium Chloride, Dietary; Sympathetic Nervous System; Time Factors | 2015 |
AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat.
Topics: Afferent Pathways; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Axonal Transport; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Conditioning, Classical; Disease Models, Animal; Dysgeusia; Female; Indoles; Male; Microinjections; Motion Sickness; Nerve Endings; Paraventricular Hypothalamic Nucleus; Polymorphism, Single Nucleotide; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Vasopressin; RNA, Messenger; Rotation; Saccharin; Synaptophysin; Vestibular Nuclei | 2015 |
Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Corticotropin-Releasing Hormone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hypothalamus; Male; Mice; Olfactory Bulb; Receptors, Corticotropin-Releasing Hormone; Receptors, Vasopressin; Signal Transduction; Venlafaxine Hydrochloride | 2016 |
Possible contribution of epigenetic changes in the development of schizophrenia-like behavior in vasopressin-deficient Brattleboro rats.
Topics: Acetylation; Animals; Arginine Vasopressin; Disease Models, Animal; Epigenesis, Genetic; Female; Hippocampus; Histones; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Prepulse Inhibition; Rats, Brattleboro; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Septum of Brain; Social Behavior | 2016 |
Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.
Topics: Animals; Arginine Vasopressin; Chromosomes, Artificial, Bacterial; Circadian Rhythm; Disease Models, Animal; Disease Progression; Female; Founder Effect; Gene Expression; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Motor Activity; Rotarod Performance Test; Sex Factors; Suprachiasmatic Nucleus; Time Factors; Vasoactive Intestinal Peptide | 2016 |
Sexual dimorphism in gene expression after aneurysmal subarachnoid hemorrhage.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cerebrovascular Circulation; Disease Models, Animal; Female; Gene Expression Regulation; Heart Rate; Intercellular Adhesion Molecule-1; Interleukin-1beta; Intracranial Pressure; Male; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Sex Characteristics; Subarachnoid Hemorrhage; Thrombomodulin; Time Factors; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2015 |
PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.
Topics: Animals; Aquaporins; Arginine Vasopressin; Disease Models, Animal; Kidney; Male; Mice; Polyuria; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Streptozocin; Water | 2016 |
The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice.
Topics: Animals; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Indoles; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pentylenetetrazole; Pyrrolidines; Receptors, Vasopressin; Seizures | 2016 |
Exposure to alcohol during adolescence exerts long-term effects on stress response and the adult brain stress circuits.
Topics: Animals; Arginine Vasopressin; Brain; Central Nervous System Depressants; Corticosterone; Disease Models, Animal; Ethanol; Male; Phenylethanolamine N-Methyltransferase; Proto-Oncogene Proteins c-fos; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological | 2016 |
Hypothalamic Vasopressinergic Projections Innervate Central Amygdala GABAergic Neurons: Implications for Anxiety and Stress Coping.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Anxiety; Arginine Vasopressin; Behavior, Animal; Central Amygdaloid Nucleus; Disease Models, Animal; GABAergic Neurons; Glutamate Decarboxylase; Hypothalamus; Male; Maternal Deprivation; Neurons; Paraventricular Hypothalamic Nucleus; Rats, Wistar; Receptors, Vasopressin; Supraoptic Nucleus; Water Deprivation | 2016 |
A novel mouse model for acute and long-lasting consequences of early life stress.
Topics: Acute Disease; Age Factors; Animals; Anxiety; Arginine Vasopressin; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Environment; Female; Hippocampus; Housing, Animal; Hypothalamus; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Nesting Behavior; Pregnancy; RNA, Messenger; Stress, Psychological | 2008 |
Neurophysiology of supraoptic neurons in C57/BL mice studied in three acute in vitro preparations.
Topics: Animals; Arginine Vasopressin; Body Fluids; Calcium; Disease Models, Animal; Exocytosis; Homeostasis; Hypothalamus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Models, Genetic; Neurons; Neurosecretory Systems; Oxytocin; Supraoptic Nucleus; Water-Electrolyte Balance | 2008 |
Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Water; Brain; Brain Edema; Carotid Arteries; Disease Models, Animal; Electrolytes; Humans; Hypoxia, Brain; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Survival Rate | 2008 |
Pathophysiological role of aquaporin-2 in impaired water excretion.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Bucladesine; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Gene Expression Regulation; Genes, Reporter; Heart Failure; Inappropriate ADH Syndrome; Kidney; Luciferases; Promoter Regions, Genetic; Rats; RNA, Messenger; Water-Electrolyte Imbalance | 2008 |
Time course changes of vasopressin-induced enlargement of the rat intrastrial space and the effects of a vasopressin type 2 antagonist.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Endolymphatic Hydrops; Injections, Subcutaneous; Meniere Disease; Microscopy, Electron, Transmission; Premedication; Rats; Stria Vascularis | 2009 |
Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Hyperemia; Hypertension, Portal; Ligation; Liver Diseases; Male; Mesenteric Artery, Superior; Portal Vein; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Vasoconstrictor Agents; Vasodilation; Vasopressins; Water Deprivation | 2009 |
Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Chronic Disease; Colon; Disease Models, Animal; Drug Administration Schedule; Female; Gastrointestinal Agents; Hyperalgesia; Indoles; Male; Mechanotransduction, Cellular; Pain Threshold; Pressure; Pyrazoles; Pyrrolidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Receptors, Vasopressin; Stress, Psychological; Time Factors; Triazines | 2009 |
Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arginine Vasopressin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Memory Disorders; Nootropic Agents; Peptide Fragments; Rats; Rats, Wistar; Synaptic Transmission; Time Factors | 2009 |
Thermoregulation and vasopressin secretion during polymicrobial sepsis.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Body Temperature Regulation; Disease Models, Animal; Disease Progression; Hypotension; Hypothalamus; Laparotomy; Male; Mortality; Nitric Oxide; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Sepsis; Shock, Septic; Supraoptic Nucleus; Up-Regulation | 2009 |
Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Blotting, Western; Brain; Brain Stem; Common Bile Duct; Disease Models, Animal; Drinking; Hematocrit; Immunohistochemistry; Inappropriate ADH Syndrome; Ligation; Liver Cirrhosis, Experimental; Male; Membrane Microdomains; Neurons; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Renin; Supraoptic Nucleus; TRPV Cation Channels; Water-Electrolyte Balance | 2009 |
Cerebral effects of three resuscitation protocols in uncontrolled haemorrhagic shock: a randomised controlled experimental study.
Topics: Animals; Arginine Vasopressin; Brain; Cerebrovascular Circulation; Clinical Protocols; Combined Modality Therapy; Disease Models, Animal; Female; Fluid Therapy; Hydroxyethyl Starch Derivatives; Hypertonic Solutions; Male; Norepinephrine; Oxygen Consumption; Plasma Substitutes; Prospective Studies; Random Allocation; Resuscitation; Shock, Hemorrhagic; Swine; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Blocking central leukotrienes synthesis affects vasopressin release during sepsis.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Glutathione Transferase; Hematocrit; Hypotension; Hypothalamus; Indoles; Leukotriene C4; Leukotrienes; Lipoxygenase Inhibitors; Male; Nitric Oxide; Pituitary Gland, Posterior; Rats; Rats, Wistar; Sepsis | 2009 |
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation | 2009 |
Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus.
Topics: Animals; Arginine Vasopressin; C-Reactive Protein; Cell Death; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Drinking; Eating; Endoplasmic Reticulum; Female; Gene Knock-In Techniques; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nerve Tissue Proteins; Neurons; Polyuria; RNA, Messenger; Supraoptic Nucleus | 2009 |
Cardiac output by arterial pulse contour: reliability under hemodynamic derangements.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; Echocardiography, Transesophageal; Equipment Design; Hemorrhage; Hydroxyethyl Starch Derivatives; Monitoring, Physiologic; Plasma Substitutes; Reproducibility of Results; Swine; Tachycardia; Thermodilution; Vasoconstriction; Vasoconstrictor Agents | 2009 |
Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Drug Therapy, Combination; Endotoxemia; Injections, Intraventricular; Injections, Subcutaneous; Lipopolysaccharides; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2009 |
Benzamil prevents brain water accumulation in hyponatraemic rats.
Topics: Amiloride; Animals; Arginine Vasopressin; Brain; Brain Edema; Disease Models, Animal; Glucose; Hyponatremia; Injections, Intraventricular; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Sodium Channels; Sodium Chloride; Water-Electrolyte Balance | 2009 |
Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Feces; Heart; Kidney; Liver; Norepinephrine; Peritonitis; Random Allocation; Shock, Septic; Swine | 2009 |
Long-term hypoxia enhances ACTH response to arginine vasopressin but not corticotropin-releasing hormone in the near-term ovine fetus.
Topics: Acclimatization; Adrenocorticotropic Hormone; Altitude; Animals; Arginine Vasopressin; Chronic Disease; Corticotropin-Releasing Hormone; Disease Models, Animal; Female; Fetal Blood; Fetal Hypoxia; Gene Expression Regulation, Developmental; Gestational Age; Hydrocortisone; Hypothalamo-Hypophyseal System; Pituitary Gland, Anterior; Pituitary-Adrenal System; Pregnancy; Receptors, Vasopressin; RNA, Messenger; Sheep; Time Factors | 2009 |
Arginine-vasopressin attenuates beneficial norepinephrine effect on jejunal mucosal tissue oxygenation during endotoxinaemia.
Topics: Acute Disease; Animals; Arginine Vasopressin; Disease Models, Animal; Endotoxemia; Female; Hemodynamics; Intestinal Mucosa; Jejunum; Male; Microcirculation; Norepinephrine; Oxygen; Oxygen Consumption; Partial Pressure; Sus scrofa; Vasoconstrictor Agents | 2009 |
Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
Topics: Animals; Arginine Vasopressin; Base Sequence; Disease Models, Animal; DNA Primers; Hypothalamo-Hypophyseal System; In Situ Hybridization; Inflammation; Male; Nociceptin; Opioid Peptides; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
Evidence of vasopressinergic-noradrenergic mechanisms in depression with above-normal plasma vasopressin concentration with and without psychotic features.
Topics: Adult; Animals; Arginine Vasopressin; Cross-Sectional Studies; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disease Models, Animal; Female; Humans; Male; Middle Aged; Norepinephrine; Psychotic Disorders; Severity of Illness Index | 2011 |
Binge-pattern alcohol exposure during puberty induces sexually dimorphic changes in genes regulating the HPA axis.
Topics: Adaptation, Physiological; Alcohol Drinking; Animals; Arginine Vasopressin; Brain; Central Nervous System Depressants; Corticotropin-Releasing Hormone; Disease Models, Animal; Ethanol; Female; Gene Expression Regulation; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Sex Characteristics; Sexual Maturation | 2010 |
Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine Vasopressin; Disease Models, Animal; Female; Humans; Male; Middle Aged; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Shock, Septic; Supraoptic Nucleus | 2010 |
Juvenile social experience regulates central neuropeptides relevant to emotional and social behaviors.
Topics: Animals; Anxiety Disorders; Arginine Vasopressin; Behavior, Animal; Cell Count; Disease Models, Animal; Female; Immunohistochemistry; Male; Maze Learning; Mood Disorders; Oxytocin; Paraventricular Hypothalamic Nucleus; Rats; Rats, Long-Evans; Social Behavior; Social Isolation | 2010 |
Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Heart Rate; Hormone Antagonists; Hypertension; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; Receptors, Adrenergic, alpha-1; Receptors, Vasopressin; Saline Solution, Hypertonic; Sodium; Sodium Chloride, Dietary; Sympathetic Nervous System; Time Factors; Vasoconstriction | 2010 |
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB.
Topics: Actigraphy; Age Factors; Analysis of Variance; Animals; Arginine Vasopressin; Behavior, Animal; Circadian Rhythm; Disease Models, Animal; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Motor Activity; Mucopolysaccharidosis III; Photoperiod; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide | 2010 |
Sex- and age-specific effects of nutrition in early gestation and early postnatal life on hypothalamo-pituitary-adrenal axis and sympathoadrenal function in adult sheep.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Age Factors; Animal Nutritional Physiological Phenomena; Animals; Arginine Vasopressin; Biomarkers; Body Composition; Corticotropin-Releasing Hormone; Disease Models, Animal; Epinephrine; Female; Gestational Age; Hydrocortisone; Hypothalamo-Hypophyseal System; Injections, Intravenous; Male; Malnutrition; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Prenatal Nutritional Physiological Phenomena; Sex Factors; Sheep; Sympathetic Nervous System; Weight Gain | 2010 |
Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Collateral Circulation; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprost; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Male; Membrane Proteins; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Portal Pressure; Portal System; Rats; Rats, Sprague-Dawley; RNA, Messenger; Simvastatin; Thromboxane B2; Thromboxane-A Synthase; Time Factors; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression.
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Bifidobacterium; Biogenic Monoamines; Brain; Citalopram; Concanavalin A; Corticosterone; Corticotropin-Releasing Hormone; Cytokines; Depression; Disease Models, Animal; Female; Lipopolysaccharides; Maternal Deprivation; Probiotics; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Tryptophan | 2010 |
Dehydration followed by sham rehydration contributes to reduced neuronal activation in vasopressinergic supraoptic neurons after water deprivation.
Topics: Afferent Pathways; Animals; Arginine Vasopressin; Dehydration; Disease Models, Animal; Fluid Therapy; Gastric Fistula; Hematocrit; Male; Neural Inhibition; Oropharynx; Osmolar Concentration; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reflex; Stomach; Supraoptic Nucleus; Time Factors; Water Deprivation | 2010 |
Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.
Topics: Adenylyl Cyclases; Animals; Aquaporin 2; Arginine Vasopressin; Blotting, Western; Cyclic AMP; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney Medulla; Kidney Tubules, Collecting; Mice; Mice, Inbred Strains; Osmolar Concentration; Phosphorylation; Polymerase Chain Reaction; Random Allocation; RNA, Messenger; Sensitivity and Specificity; Water Deprivation; Water-Electrolyte Balance | 2010 |
Role of selective V1a receptor agonism in ovine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Disease Models, Animal; Female; Hemodynamics; Immunohistochemistry; Kaplan-Meier Estimate; Norepinephrine; Oxygen Consumption; Pulmonary Gas Exchange; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin | 2011 |
Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury.
Topics: Acute Lung Injury; Animals; Arginine Vasopressin; Cardiac Output; Central Venous Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hemodynamics; Oxygen Consumption; Pulmonary Gas Exchange; Random Allocation; Reference Values; Sheep; Sheep, Domestic; Smoke Inhalation Injury; Stroke Volume; Tyrosine; Vascular Resistance; Vasoconstrictor Agents | 2011 |
Mirror, mirror on the wall: Which is the best vasopressin receptor of them all?
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hemodynamics; Humans; Norepinephrine; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin | 2011 |
ALI: Acute lung injury, or arginine-vasopressin limits inflammation, or both?
Topics: Acute Lung Injury; Animals; Arginine Vasopressin; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Nitric Oxide; Pneumonia; Risk Factors; Sheep; Sheep, Domestic; Survival Rate; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.
Topics: Aggression; Analysis of Variance; Animals; Arginine Vasopressin; Autistic Disorder; Autoradiography; Cells, Cultured; Cognition; Disease Models, Animal; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Knockout; Neurons; Oxytocin; Receptors, Oxytocin; Seizures; Social Behavior | 2011 |
Further analysis of behavioral and endocrine consequences of chronic exposure of male Wistar rats to subtoxic doses of endocrine disruptor chlorobenzenes.
Topics: Adrenocorticotropic Hormone; Aggression; Animals; Anxiety; Arginine Vasopressin; Cells, Cultured; Chlorobenzenes; Disease Models, Animal; Drug Administration Schedule; Environmental Pollutants; Hexachlorobenzene; Male; Maze Learning; Motor Activity; Norepinephrine; Oxytocin; Pituitary Gland, Posterior; Rats; Rats, Wistar; Serotonin | 2011 |
Structural and functional changes in the suprachiasmatic nucleus following chronic circadian rhythm perturbation.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Chronobiology Disorders; Disease Models, Animal; Gastrointestinal Hormones; Gene Expression Regulation; Male; Motor Activity; Neuropeptides; Period Circadian Proteins; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Suprachiasmatic Nucleus; Time Factors | 2011 |
Female responses to acute and repeated restraint stress differ from those in males.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Body Weight; Brain; Disease Models, Animal; Female; Gene Expression Regulation; Male; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Restraint, Physical; Sex Characteristics; Stress, Psychological; Time Factors | 2011 |
Ischemia-induced stimulation of Na-K-Cl cotransport in cerebral microvascular endothelial cells involves AMP kinase.
Topics: Adenylate Kinase; Animals; Arginine Vasopressin; Blood-Brain Barrier; Blotting, Western; Bumetanide; Cattle; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Enzyme Activation; Fluorescent Antibody Technique; Glucose; Infarction, Middle Cerebral Artery; Male; Microvessels; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Time Factors; Up-Regulation | 2011 |
Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.
Topics: Alcohol Drinking; Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Central Nervous System Depressants; Disease Models, Animal; Ethanol; Hypothalamus; Indoles; Italy; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Vasopressin; RNA, Messenger; Time Factors | 2011 |
Anti-depression effects of Danggui-Shaoyao-San, a fixed combination of Traditional Chinese Medicine, on depression model in mice and rats.
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Mice; Phytotherapy; Pituitary Gland; Plants, Medicinal; Rats; Rats, Sprague-Dawley; RNA, Messenger; Swimming | 2011 |
NC1900, an arginine vasopressin analogue, fails to reduce brain edema and improve neurobehavioral deficits in an intracerebral hemorrhagic stroke mice model.
Topics: Analysis of Variance; Animals; Aquaporin 4; Arginine Vasopressin; Basal Ganglia; Brain Edema; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gait Disorders, Neurologic; Male; Mice; Movement Disorders; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors | 2011 |
Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Arginine Vasopressin; Collateral Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Gene Expression Regulation; GTP-Binding Protein alpha Subunits; Hemodynamics; Hypertension, Portal; Liver Circulation; Male; Propranolol; Rats; Rats, Sprague-Dawley; Signal Transduction; Suramin; Vasoconstrictor Agents | 2011 |
Augmented central nitric oxide production inhibits vasopressin release during hemorrhage in acute alcohol-intoxicated rodents.
Topics: Alcoholic Intoxication; Animals; Arginine Vasopressin; Blood Pressure; Blood Volume; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Hemorrhage; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Osmolar Concentration; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Signal Transduction; Supraoptic Nucleus; Time Factors; Up-Regulation | 2011 |
Effects of renal denervation on the NKCC2 cotransporter in the thick ascending limb of the loop of Henle in rats with congestive heart failure.
Topics: Animals; Arginine Vasopressin; Cyclic AMP; Disease Models, Animal; Heart Failure; Loop of Henle; Male; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Sympathectomy; Sympathetic Nervous System; Time Factors | 2012 |
Reduced aldehyde dehydrogenase activity and arginine vasopressin receptor 2 expression in the kidneys of male TALLYHO/JngJ mice of prediabetic age.
Topics: Aldehyde Dehydrogenase; Animals; Arginine Vasopressin; Bowman Capsule; Case-Control Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Kidney; Male; Matched-Pair Analysis; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Organ Size; Receptors, Vasopressin; Reference Values; Sex Factors; Water-Electrolyte Balance | 2011 |
Changes in CRH and ACTH synthesis during experimental and human septic shock.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Disease Models, Animal; Humans; Immunohistochemistry; In Situ Hybridization; Nitric Oxide Synthase Type II; Rats; Receptors, Vasopressin; RNA, Messenger; Shock, Septic | 2011 |
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Body Weight; Chlorides; Disease Models, Animal; Diuretics; Dogs; Furosemide; Heart Failure; Kidney; Male; Potassium; Renin; Sodium; Tolvaptan | 2011 |
Disrupted circadian rhythms in a mouse model of schizophrenia.
Topics: Adult; Animals; Arginine Vasopressin; Circadian Rhythm; Corticosterone; Disease Models, Animal; Female; Humans; Male; Mice; Microarray Analysis; Middle Aged; Motor Activity; Polymerase Chain Reaction; Schizophrenia; Sleep; Suprachiasmatic Nucleus; Synaptosomal-Associated Protein 25; Videotape Recording | 2012 |
Development of an experimental model to study the pathophysiology of cerebral salt wasting following subarachnoid hemorrhage.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Body Weight; Cerebral Cortex; Disease Models, Animal; Drinking; Eating; Enzyme-Linked Immunosorbent Assay; Hyponatremia; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors | 2012 |
Hypothalamic vasopressin system regulation by maternal separation: its impact on anxiety in rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anxiety; Arginine Vasopressin; Brain Mapping; Conditioning, Psychological; Disease Models, Animal; Gene Expression Regulation, Developmental; Hypothalamus; Male; Maternal Deprivation; Maze Learning; Oncogene Proteins v-fos; Rats; Rats, Wistar; RNA, Messenger; Water Deprivation | 2012 |
Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Blood Pressure; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Heart Failure; Hormone Antagonists; Hypertension; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptides; Rats; Rats, Inbred Dahl; Receptors, Vasopressin; RNA, Messenger; Sodium Chloride, Dietary; Time Factors; Tolvaptan; Ultrasonography; Urination; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Alteration of antral and proximal colonic motility induced by chronic psychological stress involves central urocortin 3 and vasopressin in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Colon; Corticotropin-Releasing Hormone; Disease Models, Animal; Duodenum; Fasting; Gastrointestinal Diseases; Gastrointestinal Motility; Hormone Antagonists; Hypothalamus; Immune Sera; Indoles; Injections, Intraventricular; Male; Manometry; Oxytocin; Pressure; Pyloric Antrum; Pyrrolidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Vasopressin; RNA, Messenger; Stress, Psychological; Time Factors; Up-Regulation; Urocortins | 2012 |
Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis.
Topics: Angiopoietin-2; Animals; Arginine Vasopressin; Arterial Pressure; Blood Vessels; Capillary Permeability; Disease Models, Animal; Female; Hemodynamics; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Neutrophil Infiltration; Nitric Oxide; Pneumonia, Staphylococcal; Receptors, Vasopressin; Sepsis; Sheep; Smoke Inhalation Injury; Time Factors; Tyrosine; Vascular Endothelial Growth Factor A; Vasoconstriction; Vasoconstrictor Agents; Vasotocin; Ventricular Function, Left | 2012 |
Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
Topics: Animals; Anthracenes; Arginine Vasopressin; Basilar Artery; Carbamates; Celecoxib; Disease Models, Animal; Endothelin-1; KCNQ Potassium Channels; Male; Membrane Transport Modulators; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Pyrazoles; Rats; Rats, Sprague-Dawley; Serotonin; Signal Transduction; Subarachnoid Hemorrhage; Sulfonamides; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasospasm, Intracranial | 2013 |
Regulation of cardiac melusin gene expression by hypertrophic stimuli in the rat.
Topics: Angiotensinogen; Animals; Animals, Newborn; Arginine Vasopressin; Cell Line; Cytoskeletal Proteins; Disease Models, Animal; Gene Expression Regulation; Heart Atria; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Muscle Proteins; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Transgenic; Renin; RNA, Messenger; Signal Transduction; Time Factors | 2013 |
The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
Topics: Administration, Oral; Amlodipine; Angina Pectoris; Animals; Arginine Vasopressin; Azetidinecarboxylic Acid; Blood Pressure; Calcium; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Male; Myocardium; Oxygen Consumption; Rats; Swine; Time Factors; Vasoconstriction | 2013 |
Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Arginine Vasopressin; Body Temperature; Cardiovascular Abnormalities; Choline O-Acetyltransferase; Disease Models, Animal; Electrocardiography; Electroencephalography; Heart Rate; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Multiple System Atrophy; Myelin Proteolipid Protein; Nucleus Accumbens; Oligodendroglia; Time Factors | 2013 |
Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats.
Topics: Angiotensin II; Animals; Antibodies; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arterial Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hormone Antagonists; Hypertension, Renovascular; Intercellular Signaling Peptides and Proteins; Kidney; Male; Medulla Oblongata; Microinjections; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sympathetic Nervous System; Time Factors | 2013 |
Impaired urinary concentrating ability in genetically polyuric mice.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Animals; Arginine Vasopressin; Body Weight; Cyclic AMP; Disease Models, Animal; Drinking; Female; Kidney Concentrating Ability; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Transgenic; Osmolar Concentration; Polyuria | 2002 |
Arginine vasopressin in the pathogenesis of febrile convulsion and temporal lobe epilepsy.
Topics: Animals; Animals, Newborn; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Convulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Male; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures, Febrile; Status Epilepticus; Survival Rate | 2002 |
[Neurobiology and genetics of anxiety in an animal model].
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine Vasopressin; Arousal; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Motor Activity; Paroxetine; Phenotype; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Receptors, Vasopressin | 2003 |
Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Monitoring; Drug Therapy, Combination; Endotoxemia; Female; Heart Rate; Hemodynamics; Infusions, Intravenous; Norepinephrine; Oxygen Consumption; Prospective Studies; Pulmonary Wedge Pressure; Respiratory Transport; Sheep; Typhoid Fever; Vascular Resistance; Vasoconstrictor Agents | 2003 |
A neurodevelopmental model for anorexia nervosa.
Topics: Adaptation, Psychological; Adolescent; Adrenocorticotropic Hormone; Adult; Animals; Anorexia Nervosa; Arginine Vasopressin; Arousal; Brain; Child; Corticotropin-Releasing Hormone; Disease Models, Animal; Diseases in Twins; Female; Genetic Predisposition to Disease; Helplessness, Learned; Humans; Hypothalamo-Hypophyseal System; Male; Object Attachment; Pituitary-Adrenal System; Puberty; Risk Factors; Stress, Psychological | 2003 |
A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.
Topics: Animals; Apoptosis; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Drinking; Hypothalamus; Immunohistochemistry; Mice; Mutation; Neurons; Protein Precursors; Urination | 2003 |
Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats.
Topics: Animals; Arginine Vasopressin; Dependovirus; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Hypothalamus, Anterior; Immunohistochemistry; Osmolar Concentration; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Brattleboro | 2003 |
Arginine vasopressin compromises gut mucosal microcirculation in septic rats.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Infusions, Intravenous; Intestinal Mucosa; Male; Microcirculation; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Risk Factors; Sensitivity and Specificity; Shock, Septic | 2004 |
Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage.
Topics: Animals; Arginine Vasopressin; Basilar Artery; Disease Models, Animal; Female; Indoles; Pyrans; Pyrrolidines; Quinolones; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2004 |
Upregulation of corticotropin-releasing hormone gene expression in the paraventricular nucleus of cyclophosphamide-induced cystitis in male rats.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Cyclophosphamide; Cystitis; Disease Models, Animal; Gene Expression Regulation; In Situ Hybridization; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nociceptors; Pain; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Up-Regulation; Urinary Bladder; Visceral Afferents | 2004 |
Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Lithium Carbonate; Lypressin; Mice; Motor Activity; Neomycin; Phospholipids; Piperidines; Polyuria; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Sphingosine | 2004 |
Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats.
Topics: Animals; Arginine Vasopressin; Desoxycorticosterone; Disease Models, Animal; Hypertension; Hypothalamus; Immunohistochemistry; In Situ Hybridization; Male; Mineralocorticoids; Oncogene Proteins v-fos; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Vasopressin; RNA, Messenger; Vasopressins | 2004 |
Use of vasopressin in a canine model of severe verapamil poisoning: a preliminary descriptive study.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Overdose; Heart Rate; Poisoning; Shock; Survival Analysis; Treatment Outcome; Vasoconstrictor Agents; Verapamil | 2004 |
Residual urinary concentrating ability and AQP2 expression in a rat model for chronic renal failure.
Topics: Animals; Arginine Vasopressin; Dehydration; Disease Models, Animal; Kidney; Kidney Concentrating Ability; Kidney Failure, Chronic; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley | 2005 |
Effects of intravenous arginine vasopressin on epicardial coronary artery cross sectional area in a swine resuscitation model.
Topics: Anatomy, Cross-Sectional; Animals; Arginine Vasopressin; Coronary Vessels; Disease Models, Animal; Heart Arrest; Hemodynamics; Injections, Intravenous; Reference Values; Swine; Ultrasonography, Interventional; Vasoconstrictor Agents; Ventricular Fibrillation | 2005 |
Preliminary evidence for reduced social interactions in Chakragati mutants modeling certain symptoms of schizophrenia.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Disease Models, Animal; Female; Heterozygote; Homozygote; Hypothalamus, Anterior; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; Motor Activity; Mutation; Oxytocin; Schizophrenia; Schizophrenic Psychology; Social Behavior; Stereotyped Behavior; Tissue Distribution | 2005 |
Antidepressant-like effects of BCEF0083 in the chronic unpredictable stress models in mice.
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Body Weight; Chronic Disease; Depression; Disease Models, Animal; Escape Reaction; Fungi; Male; Mice; Reward | 2005 |
Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Blood Glucose; Brain; Demyelinating Diseases; Disease Models, Animal; Hyponatremia; Inositol; Male; Mannitol; Neurologic Examination; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Sodium Chloride; Staining and Labeling; Survival Rate; Time Factors; Urea; Vitamin B Complex | 2006 |
Vasopressin: multitalented hormone among the shock hormones?
Topics: Animals; Arginine Vasopressin; Brain Injuries; Disease Models, Animal; Fluid Therapy; Heart Arrest; Humans; Shock, Hemorrhagic; Swine; Vasoconstrictor Agents | 2006 |
Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats.
Topics: Anaphylaxis; Anesthesia; Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Epinephrine; Hypotension; Lypressin; Oxygen; Rats; Rats, Inbred BN; Terlipressin | 2006 |
Possible new mechanism underlying hypertonic saline therapy for cerebral edema.
Topics: Animals; Arginine Vasopressin; Brain Edema; Disease Models, Animal; Humans; Ischemic Attack, Transient; Male; Mannitol; Rats; Saline Solution, Hypertonic | 2006 |
Arginine vasopressin in the caudate nucleus plays an antinociceptive role in the rat.
Topics: Animals; Arginine Vasopressin; Caudate Nucleus; Disease Models, Animal; Electric Stimulation; Pain; Pain Measurement; Potassium; Rats | 2006 |
Cerebral metabolism assessed with microdialysis in uncontrolled hemorrhagic shock after penetrating liver trauma.
Topics: Animals; Arginine Vasopressin; Carbon Dioxide; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Female; Fluid Therapy; Hemodynamics; Intracranial Pressure; Liver; Male; Microdialysis; Oxygen; Partial Pressure; Shock, Hemorrhagic; Swine; Wounds and Injuries | 2006 |
Chronic cyclooxygenase blockade enhances the vasopressin responsiveness in collaterals of portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Collateral Circulation; Cyclooxygenase Inhibitors; Disease Models, Animal; Hypertension, Portal; Indomethacin; Portal System; Random Allocation; Rats; Vascular Resistance | 2006 |
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Water; Water-Electrolyte Balance | 2007 |
Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Blood-Brain Barrier; Brain; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Male; Rats; Rats, Long-Evans; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2006 |
Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Topics: Animals; Animals, Newborn; Arginine Vasopressin; Atrial Natriuretic Factor; Cardiomegaly; Cell Enlargement; Cells, Cultured; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Immunohistochemistry; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Piperidines; Protein Biosynthesis; Quinolones; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic; Vasoconstrictor Agents | 2007 |
Total peripheral resistance responsiveness during the development of secondary renal hypertension in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Cardiac Output; Disease Models, Animal; Dogs; Enalapril; Ganglionic Blockers; Hypertension, Renovascular; Male; Pentolinium Tartrate; Phenylephrine; Vascular Resistance; Vasoconstrictor Agents | 2007 |
Prenatal stress increases HPA axis activity and impairs maternal care in lactating female offspring: implications for postpartum mood disorder.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Female; Hypothalamo-Hypophyseal System; Lactation; Maternal Behavior; Mood Disorders; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Puerperal Disorders; Rats; Rats, Wistar; RNA, Messenger; Stress, Psychological | 2007 |
Comparison of treatment modalities for hemorrhagic shock.
Topics: Animals; Arginine Vasopressin; Blood Substitutes; Conjunctiva; Disease Models, Animal; Dogs; Female; Hemoglobins; Hydroxyethyl Starch Derivatives; Male; Microcirculation; Microscopy, Video; Monitoring, Physiologic; Plasma Substitutes; Shock, Hemorrhagic; Vasoconstrictor Agents | 2007 |
Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine Vasopressin; Disease Models, Animal; Female; Glycopeptides; Humans; Male; Middle Aged; Papio ursinus; Protein Precursors; Retrospective Studies; Shock, Hemorrhagic; Shock, Septic | 2007 |
Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice.
Topics: Analysis of Variance; Animals; Anxiety; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Frontal Lobe; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Random Allocation; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Species Specificity; Stress, Psychological; Tissue Distribution | 2007 |
The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Arginine Vasopressin; Clozapine; Deamino Arginine Vasopressin; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Habituation, Psychophysiologic; Haloperidol; Neural Inhibition; Neurotensin; Rats; Rats, Brattleboro; Rats, Long-Evans; Rats, Mutant Strains; Reflex, Startle; Risperidone; Schizophrenia; Statistics, Nonparametric | 2007 |
Effects of low-volume hemoglobin glutamer-200 versus normal saline and arginine vasopressin resuscitation on systemic and skeletal muscle blood flow and oxygenation in a canine hemorrhagic shock model.
Topics: Animals; Arginine Vasopressin; Blood Circulation; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Female; Heart Rate; Hemoglobins; Male; Muscles; Oxygen; Random Allocation; Resuscitation; Shock, Hemorrhagic | 2007 |
Arginine vasopressin increases iNOS-NO system activity in cardiac fibroblasts through NF-kappaB activation and its relation with myocardial fibrosis.
Topics: Animals; Arginine Vasopressin; Cardiomyopathies; Cells, Cultured; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Fibroblasts; Fibrosis; Fluorescent Antibody Technique; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Myocardium; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spectrophotometry; Thiocarbamates | 2007 |
Arginine vasopressin during sinus rhythm: effects on haemodynamic variables, left anterior descending coronary artery cross sectional area and cardiac index, before and after inhibition of NO-synthase, in pigs.
Topics: Anatomy, Cross-Sectional; Animals; Arginine Vasopressin; Coronary Vessels; Disease Models, Animal; Heart Arrest; Injections, Intravenous; Nitric Oxide Synthase; Swine; Ultrasonography, Interventional; Vasoconstrictor Agents; Ventricular Fibrillation | 2007 |
Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Collateral Circulation; Common Bile Duct; Disease Models, Animal; Enzyme Inhibitors; Heart Rate; Ligation; Liver; Liver Circulation; Liver Cirrhosis, Biliary; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Portal Pressure; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction | 2008 |
Release of protein S100B in haemorrhagic shock: effects of small volume resuscitation combined with arginine vasopressin.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Cerebrovascular Circulation; Colloids; Crystalloid Solutions; Disease Models, Animal; Female; Hemostatics; Intracranial Pressure; Isotonic Solutions; Liver; Male; Nerve Growth Factors; Prospective Studies; Rehydration Solutions; Resuscitation; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Saline Solution, Hypertonic; Shock, Hemorrhagic; Swine | 2008 |
Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice.
Topics: Animals; Arginine Vasopressin; Body Weight; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Eating; Female; Gene Expression Profiling; Hypothalamus; Injections, Subcutaneous; Janus Kinase 2; Leptin; Mice; Mice, Obese; Nerve Tissue Proteins; Neuropeptide Y; Obesity; Pro-Opiomelanocortin; RNA, Messenger; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thinness; Urocortins | 2007 |
The effects of transient cerebral ischemia on vasopressin-induced vasoconstriction in rabbit cerebral vessels.
Topics: Administration, Topical; Animals; Arginine Vasopressin; Arterioles; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Hypotension; Pia Mater; Rabbits; Tourniquets; Vasoconstriction; Vasoconstrictor Agents | 2008 |
[Effect of arginine vasopressin on vascular reactivity and calcium sensitivity of vascular smooth muscle and its relationship to protein kinase C following hemorrhagic shock in rats].
Topics: Animals; Arginine Vasopressin; Calcium; Disease Models, Animal; Female; In Vitro Techniques; Male; Mesenteric Artery, Superior; Norepinephrine; Protein Kinase C; Rats; Rats, Wistar; Shock, Hemorrhagic; Vasoconstriction | 2008 |
Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension.
Topics: Administration, Oral; Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Disulfides; Diuresis; Drinking; Enzyme Inhibitors; Glutamyl Aminopeptidase; Hypertension; Male; Rats; Rats, Inbred Dahl; Rats, Inbred WKY; Sulfonic Acids | 2008 |
Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Hemodynamics; Hypotension; Intestines; Liver; Microcirculation; Rabbits; Shock, Septic; Splanchnic Circulation; Vasoconstrictor Agents | 2008 |
An experimental model of syndrome of inappropriate antidiuretic hormone secretion in the rat.
Topics: Animals; Arginine Vasopressin; Body Water; Deamino Arginine Vasopressin; Disease Models, Animal; Erythrocyte Count; Hyponatremia; Inappropriate ADH Syndrome; Male; Potassium; Rats; Rats, Inbred Strains; Rodent Diseases; Sodium | 1984 |
Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
Topics: Animals; Arginine Vasopressin; Brain; Brain Edema; Disease Models, Animal; Diuresis; Female; Inappropriate ADH Syndrome; Male; Natriuresis; Osmolar Concentration; Rats; Sodium; Vasopressins | 1984 |
Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat.
Topics: Adrenal Glands; Animals; Arginine Vasopressin; Corticosterone; Disease Models, Animal; Diuresis; Glomerular Filtration Rate; Glucocorticoids; Hypophysectomy; Kidney; Male; Mineralocorticoids; Rats; Thyroid Gland | 1980 |
High level of arginine vasopressin and 7.5% NaCl/6% dextran-70 solution: cardiovascular and renal effects.
Topics: Animals; Arginine Vasopressin; Cardiovascular System; Dextrans; Disease Models, Animal; Hemodynamics; Infusions, Intravenous; Kidney; Sheep; Shock, Hemorrhagic; Sodium Chloride | 1994 |
Different responses of renal blood flow and sympathetic nerve activity to captopril and nicardipine in conscious renal hypertensive rabbits.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Female; Heart Rate; Hypertension, Renal; Kidney; Nicardipine; Norepinephrine; Rabbits; Regional Blood Flow; Renal Circulation; Sympathetic Nervous System; Vascular Resistance; Vasodilation | 1995 |
Aggressive role of vasopressin in development of different gastric lesions in rats.
Topics: Animals; Arginine Vasopressin; Autoradiography; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Female; Gastric Mucosa; Hemorrhage; Indomethacin; Lypressin; Rats; Rats, Wistar; Reserpine; Vasopressins | 1994 |
Effect of long-term administration of 1,25 (OH)2 vitamin D3 on blood pressure and resistance artery contractility in the spontaneously hypertensive rat.
Topics: Acetylcholine; Animals; Arginine Vasopressin; Arteries; Blood Pressure; Calcitriol; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Injections, Intraperitoneal; Male; Norepinephrine; Rats; Rats, Inbred SHR; Time Factors; Vascular Resistance; Vasoconstriction | 1993 |
Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Clonidine; Disease Models, Animal; Female; Hypertension, Renovascular; Kidney; Nicardipine; Norepinephrine; Rabbits; Renin-Angiotensin System; Sympathetic Nervous System | 1993 |
Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
Topics: Acetylcholine; Angina Pectoris; Animals; Arginine Vasopressin; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Disease Models, Animal; Electrocardiography; Male; Nifedipine; Nisoldipine; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Thiazoles; Vasoconstrictor Agents | 1995 |
Cisternal talc injection in dog can induce delayed and prolonged arterial constriction resembling cerebral vasospasm morphologically and pharmacologically.
Topics: Animals; Arginine Vasopressin; Basilar Artery; Disease Models, Animal; Dogs; Ischemic Attack, Transient; Microscopy, Electron; Nitroprusside; Talc; Time Factors; Ultrasonography; Vasoconstriction | 1996 |
Lack of endothelin ETB receptor binding and function in the rat with a mutant ETB receptor gene.
Topics: Animals; Arginine Vasopressin; Binding, Competitive; Cerebellum; Disease Models, Animal; Endothelins; Lung; Megacolon; Myocardium; Rats; Rats, Mutant Strains; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstriction | 1996 |
The role of stressor intensity in influencing the course of heart disease in cardiomyopathic hamsters.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Blood Pressure; Cardiomyopathy, Dilated; Coronary Vessels; Cricetinae; Disease Models, Animal; Hemodynamics; Immobilization; Stress, Physiological; Time Factors; Vascular Resistance; Ventricular Function | 1996 |
Sustained systemic arterial hypertension induced by extended hypobaric hypoxia.
Topics: Air Pressure; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Disease Models, Animal; Erythropoietin; Hematocrit; Hypertension; Hypoxia; Male; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |
Mechanism of lithium-induced polyuria in the rat.
Topics: Animals; Arginine Vasopressin; Calcium; Diabetes Insipidus; Disease Models, Animal; Diuresis; Female; In Vitro Techniques; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Osmosis; Parathyroid Hormone; Parathyroidectomy; Polyuria; Punctures; Rats; Rats, Wistar; Syndrome | 1996 |
Hypothalamo-pituitary-adrenal axis response to coronary artery embolization: an ovine model of acute myocardial infarction.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Coronary Vessels; Corticotropin-Releasing Hormone; Disease Models, Animal; Embolism; Female; Hydrocortisone; Hypothalamo-Hypophyseal System; Myocardial Infarction; Pituitary-Adrenal System; Sheep | 1997 |
Rats go with the (urine) flow.
Topics: Adenoviridae; Animals; Arginine Vasopressin; Brain; Diabetes Insipidus; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Humans; Rats | 1997 |
Increased expression of magnocellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; RNA, Messenger; Stress, Physiological | 1998 |
Cl- absorption across the thick ascending limb is not altered in cystic fibrosis mice. A role for a pseudo-CFTR Cl- channel.
Topics: Adenosine Triphosphate; Animals; Arginine Vasopressin; Carrier Proteins; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diphosphates; Disease Models, Animal; Hydrogen-Ion Concentration; Ion Transport; Kidney; Loop of Henle; Mice; Mice, Knockout; Patch-Clamp Techniques; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium-Potassium-Chloride Symporters | 1998 |
Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Body Weight; Creatinine; Diabetes Insipidus; Disease Models, Animal; Disease Progression; Kidney; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Uremia; Vasopressins | 1999 |
A mouse model of familial amyotrophic lateral sclerosis expressing a mutant superoxide dismutase 1 shows evidence of disordered transport in the vasopressin hypothalamo-neurohypophysial axis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Arginine Vasopressin; Axonal Transport; Axons; Body Water; Cytoplasmic Granules; Disease Models, Animal; Female; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Transgenic; Mutation, Missense; Neurosecretion; Pituitary Gland; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1 | 1999 |
Systolic pressure predicts plasma vasopressin responses to hemorrhage and vena caval constriction in dogs.
Topics: Anesthetics, Local; Animals; Aorta, Thoracic; Arginine Vasopressin; Atrial Function; Baroreflex; Blood Pressure; Blood Volume; Disease Models, Animal; Dogs; Female; Ganglionic Blockers; Heart Atria; Hemorrhage; Hypovolemia; Ligation; Male; Predictive Value of Tests; Procaine; Regression Analysis; Vasopressins; Vena Cava, Inferior; Ventricular Function | 2000 |
Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Aging; Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Female; Gene Expression Regulation, Developmental; Hypothalamo-Hypophyseal System; Hypothyroidism; Methimazole; Paraventricular Hypothalamic Nucleus; Pituitary Gland, Anterior; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Supraoptic Nucleus; Thyrotropin; Transcortin | 2000 |
A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antiemetics; Antineoplastic Agents; Arginine Vasopressin; Cell Membrane; Cisplatin; Disease Models, Animal; Hormone Antagonists; Hypertension; Indoles; Liver; Pyrrolidines; Swine; Vomiting | 2001 |
The ovine fetal endocrine reflex responses to haemorrhage are not mediated by cardiac nerves.
Topics: Adrenergic alpha-Agonists; Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Blood Pressure; Blood Volume; Disease Models, Animal; Endocrine Glands; Female; Fetus; Heart; Heart Rate; Heart Rate, Fetal; Hemorrhage; Oxygen Consumption; Pericardium; Phenylephrine; Pregnancy; Procaine; Renin; Sheep | 2002 |
Reduction of free water clearance with cephalic venous hypertension.
Topics: Animals; Arginine Vasopressin; Brain; Cerebrovascular Disorders; Disease Models, Animal; Dogs; Hypertension; Hypothalamus; Osmolar Concentration; Time Factors; Vasopressins; Venous Pressure | 1978 |
Intact kidney function during contralateral renal artery clamping in dogs.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chlorides; Disease Models, Animal; Dogs; Dopamine; Female; Glomerular Filtration Rate; Heart Rate; Ischemia; Kidney; Male; Potassium; Renal Artery Obstruction; Renal Circulation; Sodium | 1992 |
Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Hypertension; Inositol Phosphates; Kidney; Liver; Male; Osmolar Concentration; Rats; Rats, Inbred Strains; Receptors, Vasopressin; Second Messenger Systems; Sodium Chloride | 1992 |
Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Heart Failure; Hemodynamics; Norepinephrine; Radioimmunoassay; Renin | 1992 |
Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Cardiac Output; Disease Models, Animal; Female; Heart Failure; Male; Rabbits; Vascular Resistance; Vasopressins | 1991 |
Increasing atrial pressure during cardiac tamponade does not elevate plasma levels of the peptide ANP in conscious dogs.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cardiac Tamponade; Consciousness; Disease Models, Animal; Dogs; Heart Atria; Hemodynamics | 1990 |
Vasopressin in oligohydramnios-induced lung hypoplasia.
Topics: Animals; Arginine Vasopressin; Body Fluids; Disease Models, Animal; Female; Fetus; Lung; Oligohydramnios; Pregnancy; Rats; Rats, Brattleboro | 1990 |
Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
Topics: Adenoma, Islet Cell; Animals; Arginine Vasopressin; Disease Models, Animal; Hybridization, Genetic; Immunohistochemistry; Mice; Mice, Transgenic; Microscopy, Electron; Oncogenes; Pancreatic Neoplasms; Pituitary Gland, Anterior; Pituitary Neoplasms; Simian virus 40 | 1987 |
Does vasopressin sustain blood pressure in conscious spontaneously hypertensive rats?
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypertension; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Vasopressins; Water Deprivation | 1986 |
Characterization of neurohormonal changes following the production of the benign and malignant phases of two-kidney, two-clip Goldblatt hypertension.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Captopril; Catecholamines; Disease Models, Animal; Dogs; Epinephrine; Hexamethonium; Hexamethonium Compounds; Hypertension, Malignant; Hypertension, Renovascular; Neuropeptides; Norepinephrine; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1987 |
Medroxyprogesterone acetate induces diabetes insipidus in Chinese hamsters.
Topics: Animals; Arginine Vasopressin; Cricetinae; Cricetulus; Diabetes Insipidus; Disease Models, Animal; Female; Kidney Concentrating Ability; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Polyuria; Sex Factors; Species Specificity; Vasopressins; Water Deprivation | 1986 |
Vascular vasopressin receptors in renal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Cell Membrane; Disease Models, Animal; Hypertension, Renovascular; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nephrectomy; Perfusion; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin; Reference Values | 1988 |
Role of vasopressin in experimental heart failure.
Topics: Animals; Aortic Valve Stenosis; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Dogs; Heart Failure; Pulmonary Valve Stenosis; Rats; Renin-Angiotensin System; Teprotide; Water-Electrolyte Balance | 1988 |
Simulation of acute haemorrhage in unanaesthetized rabbits.
Topics: Acute Disease; Anesthesia; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Disease Models, Animal; Heart Rate; Hematocrit; Hemorrhage; Rabbits; Renin; Vascular Resistance; Vena Cava, Inferior | 1988 |
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Deamino Arginine Vasopressin; Disease Models, Animal; Flushing; Heart Rate; Hemodynamics; Indomethacin; Macaca mulatta; Male | 1988 |
The role of vasopressin in acute cerebral vasospasm. Effect on spasm of a vasopressin antagonist or vasopressin antiserum.
Topics: Acute Disease; Animals; Arginine Vasopressin; Blood; Disease Models, Animal; Ischemic Attack, Transient; Male; Radiography; Rats; Rats, Brattleboro; Rats, Inbred Strains; Subarachnoid Hemorrhage; Vasoconstriction | 1988 |
Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
Topics: Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Disease Models, Animal; Inappropriate ADH Syndrome; Male; Rats; Vasopressins; Water Intoxication | 1986 |
Histochemical and ultrastructural study of renal cortical necrosis in rats treated with oestrone + vasopressin, and its prevention with a vasopressin antagonist.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Estrone; Histocytochemistry; Kidney; Kidney Cortex Necrosis; Lypressin; Male; Microscopy, Electron; Rats; Rats, Inbred Strains | 1987 |
Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology.
Topics: Animals; Arginine Vasopressin; Body Weight; Disease Models, Animal; Injections, Intraventricular; Male; Motor Activity; Rats; Rats, Inbred Strains; Reaction Time; Rotation; Seizures | 1986 |
Baroreflex sensitivity and pressor responses in a rat model of uraemia.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Male; Norepinephrine; Pressoreceptors; Rats; Rats, Inbred Strains; Reflex; Uremia | 1985 |